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ABSTRACT 
Photochemical and Enzymatic Method for DNA Methylation Profiling and Walking Approach 
for Increasing Read Length of DNA Sequencing by Synthesis 
Ece Erturk 
 
The first half of this dissertation demonstrates development of a novel method for DNA 
methylation profiling based on site specific conversion of cytosine in CpG sites catalyzed by DNA 
methyltransferases. DNA methylation, a chemical process by which DNA bases are modified by 
methyl groups, is one of the key epigenetic mechanisms used by cells to regulate gene expression. 
It predominantly occurs at the 5-position of cytosines in CpG sites and is essential in normal 
development. Aberrant methylation is associated with many diseases including cancer. Bisulfite 
Genomic Sequencing (BGS), the gold standard in DNA methylation profiling, works on the 
principle of converting unmethylated cytosines to uracils using sodium bisulfite under strong basic 
conditions that cause extensive DNA damage limiting its applications. This dissertation focuses 
on the research and development of a new method for single cell whole-genome DNA methylation 
profiling that will convert the unmethylated cytosines in CpG sites to thymine analogs with the aid 
of DNA methyltransferase and photo-irradiation. Previously we synthesized a model 
deoxycytidine containing an optimized allyl chemical group at the 5-position and demonstrated 
that this molecule undergoes photo-conversion to its deoxythymidine analog (C to T conversion) 
with irradiation at 300 nm. The C to T conversion also proved feasible using synthetic DNA 
molecules. In this thesis, we demonstrate the conversion of a novel modified deoxycytidine 
molecule (PhAll-dC) using 350 nm photo-irradiation and a triplet photosensitizer (thioxanthone, 
TX) to avoid potential DNA damage.  The new photoproduct was identified as the deoxythymidine 
analog of the starting molecule as assessed by IR, MS and NMR. An AdoMet analog containing 
the optimized chemical group was also synthesized and tested for enzymatic transfer to the C5-
position of CpG cytosines using DNA methyltransferases. DNA methyltansferase M.SssI was 
engineered for more efficient enzymatic transfer. In the future, we will incorporate a triplet 
photosensitizer into the photoreactive moiety on AdoMet to increase energy transfer efficiency for 
photo-conversion of C to the T analog. Incorporating this into an overall method followed by 
amplification and sequencing should allow us to assess the methylation status of all CpGs in the 
genome in an efficient manner. 
 
The second half of this dissertation demonstrates development of a DNA sequencing by synthesis 
(SBS) method, The Sequence Walking Approach, using novel nucleotide reversible terminators 
(NRTs) together with natural nucleotides. Following the completion of The Human Genome 
Project, next generation DNA sequencing technologies emerged to overcome the limitations of 
Sanger Sequencing, the prominent DNA sequencing technology of the time. These technologies 
led to significant improvements in throughput, accuracy and economics of DNA sequencing. 
Today, fluorescence-based sequencing by synthesis methods dominate the high-throughput 
sequencing market. One of the major challenges facing fluorescence-based SBS methods is their 
read length limitation which constitutes a big barrier for applications such as de novo genome 
assembly and resolving structurally complex regions of the genome. In this regard, we have 
developed a novel SBS method called ‘The Sequence Walking Approach’ to overcome current 
challenges in increasing the single pass read length of DNA sequencing. Our method utilizes three 
dNTPs together with one nucleotide reversible terminator in reactions called ‘walks’ that terminate 
at predetermined bases instead of after each incorporation. In this method, the primer extended via 
4-color SBS is stripped off and replaced by the original primer for walking reactions. By reducing 
the accumulation of cleavage artifacts of incorporated NRTs in a single run, our method aims to 
reach longer read lengths. In this thesis, we have demonstrated a variation of The Sequence 
Walking Approach in which 4-color sequencing steps are interspersed with walking steps over a 
continuous length of DNA without stripping off extended primers and reannealing the original 
primer. The improvements introduced with this method will enable the use of fluorescence-based 
SBS in many applications such as detection of genomic variants and de novo genome assemblies 
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Chapter 1. Introduction to DNA Methylation 
Epigenetic changes are chemical modifications on DNA that alter a gene’s function without 
changing its DNA sequence. Some of these epigenetic changes involve DNA methylation, histone 
modification and nucleosome positioning within DNA. The best known and studied epigenetic 
regulation mechanism, DNA methylation, is a signaling tool eukaryotic cells use to regulate gene 
expression. It occurs through covalent attachment of a methyl group on DNA cytosine residues at 
the carbon 5-position by DNA methyltransferases (DNMTs).1  
 
In mammals there are 4 different DNA methyltransferases, DNMT1, DNMT3A, DNMT3B and 
DNMT3L. Unlike the others, DNMT3L does not have active methyltransferase activity, however 
it is essential in stimulating de novo methylation by DNMT3A and DNMT3B.3 De novo DNA 
methyltransferases (DNMT3A and DNMT3B) initiate and establish a methylation pattern on an 
unmethylated DNA strand whereas maintenance DNA methyltransferase (DNMT1) copy this 
 
Fig. 1 DNA Methylation.2 DNA methylation occurs at the 5 position of Cs in CpG sites. It is catalyzed 
by DNA methyltransferases (DNMT) which transfer the methyl group from the methyl donor AdoMet 
to the 5 position of cytosines, thus converting cytosine into 5-methylcytosine. 
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methylation pattern to newly synthesized daughter DNA using hemi-methylated DNA as a 
substrate. Studies in mice show that inactivity of DNMT1, DNMT3A or DNMT3B leads to 
embryonic, fetal or postnatal death due to multiple developmental defects.4 
In normal cells, DNA methylation is mostly observed in repetitive genomic regions such as 
satellite DNA and parasitic elements. It is an effective tool for silencing gene expression and 
maintaining genome stability against extensive amounts of repetitive DNA.5 In mammals 
methylation primarily occurs in symmetrical CpG sequences.6 The human genome contains ~29 
million CpG sites, about 70-80% of which are methylated at the 5 position of cytosine.7 Less than 
10% of CpGs are present in the regions called CpG islands.6 These CpG rich areas of the genome 
are mostly found within the promoter region of genes where increased methylation is generally 
associated with transcriptional repression (Fig. 2).  
The effects of DNA methylation on suppression of a gene can be explained by two mechanisms. 
The first one is direct inhibition of sequence-specific transcription factor binding on CpG sites. 
The presence of methyl groups on CpG cytosines block these transcription factors from binding 
onto their recognition sequences which contain the methylated CpG dinucleotides. Consequently, 
the transcription of the adjacent gene is prevented. The second mechanism, although not as 
common, results from competitive binding of methyl-CpG binding proteins with transcription 








Although carrying very high importance, the complexity of genomic methylation patterns is not 
well appreciated. ~29,000,000 CpG dinucleotides in the human genome can exist in the methylated 
or unmethylated state; the number of possible methylation patterns is therefore ~108,700,000 per 
haploid genome, and methylation patterns are heterogeneous even within single tissues. The 
analysis of genomic methylation patterns is both quantitatively and qualitatively very different 
from the analysis of genome sequence. 
 
 
Fig. 2 Control of Gene Expression through DNA Methylation.8 DNA methylation patterns are 
essential in normal development. Methylation mostly occurs at CpG sites; however, the human genome 
is CpG deficient except in regions called CpG islands. These CpG islands are rich in CG dinucleotides 




1.1. Aberrant DNA Methylation and Disease 
Genomic methylation patterns are essential for normal development and cell viability as they are 
a crucial part of key processes such as embryonic development, genomic imprinting, X-
chromosome inactivation and chromosome stability.10 Studies show that there is a direct link 
between DNA methylation mechanisms and DNA damage repair systems. These systems maintain 
genomic stability and prevent diseases such as cancer as they work against genomic mutations 
leading to carcinogenesis.4 
The importance of DNA methylation is underlined by the fact that an increasing number of human 
diseases are being associated with improper methylation. Deletions of DNMT1 and 
DNMT3A/DNMT3B show that the activity of these enzymes are essential in maintaining the 
stability of the genome.4 The diverse array of diseases that have been linked to abnormal DNA 
methylation include ICF syndrome, fragile X syndrome, human cancer11, some cases of Sotos 
syndrome12, and a subset of hereditary sensorineural and dementia syndromes.13 
Carcinogenesis can be caused and driven by aberrant epigenetic changes.4 Cancer cells show 
strong and heterogeneous abnormalities in genomic methylation patterns, with global losses and 
focal gains in DNA methylation thought to play an important role in cellular transformation (Fig. 
3).14 Tumorigenesis requires that both alleles of a tumor suppressor gene are silenced by mutations 
in the coding region of the gene. An alternative mechanism to gene mutation would be the 
hypermethylation of the CpG islands in the promoter regions of the tumor suppressor genes.15 This 
is a trait found in different cancer types such as colorectal, breast and lung cancers.4,16 De novo 
methylation of CpG islands found in the promoter regions of the genes such as tumor suppressor 
genes are believed to silence gene activity and provide the cell with a growth advantage leading to 
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tumorigenesis.9 Methylation biomarkers have great promise in cancer screening and other 
applications.14 
 
1.2. DNA Methylation Analysis Technologies 
Epigenetic changes in DNA methylation status are increasingly being studied for their role in both 
normal and disease associated phenotypic changes. Projects such as the Roadmap Epigenomics 
Project have been launched by NIH to create reference epigenomes for a variety of cell types. Over 
the past decade, high-throughput DNA methylation analysis technologies have evolved to the point 
 
Fig. 3 Aberrant DNA Methylation in Cancer.17 Abnormalities in methylation are associated with many 
diseases including cancer. For example, in a normal cell CpG islands at promoter regions of the tumor 
suppressor gene are unmethylated. It is argued that hypermethylation of these regions results in 
inactivation of the tumor suppressor gene. In addition, it is thought that more generalized 
hypomethylation throughout the genome is also associated with the prevalence of cancers. 
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where they have enabled global analysis of DNA methylation patterns. Where the previous 
technology could only enable the analysis of specific loci, now it is feasible to approach entire 
methylome characterization at single base pair resolution.18,19 Over 30 genome-wide methylation 
analysis technologies have been developed and are categorized under three main approaches: 
endonuclease digestion, affinity enrichment and bisulfite conversion. These methods include 
methylation sensitive or specific restriction enzyme digestion, methyl-DNA immunoprecipitation 
(meDIP), methyl-CpG binding domain-based capture (MBDCap) and direct bisulfite treatment 
based methods.20 Among the drawbacks of these methods are extreme proneness to false-positive 
results, lower resolution coverage, sequence library biases and high sensitivity to varying CpG 
densities in the genome.18 
 
1.2.1. Specific Restriction Enzyme Digestion 
Specific restriction enzyme digestion methods aim to create a representative subset of the genome 
using methylation dependent (mcrBC) or methylation sensitive (HpaII, MspI) restriction enzymes. 
These methods enrich DNA fragments to specifically distinguish methylated and unmethylated 
portions of the genome. After restriction digestion, the enriched small fragments are amplified by 
PCR and analyzed via either microarray-based or massively parallel sequencing techniques. 
Although the method is technically simple it is limited by the amount of starting material needed, 
the positioning of recognition sites for the restriction endonuclease used, the limited number of 





1.2.2. CpG Site Affinity Capture 
Methylated DNA immunoprecipitation (meDIP) relies on immunocapture of randomly fragmented 
DNA by methylated cytosine specific antibodies to enrich methylated DNA (Fig. 4). The method 
is followed by either sequencing or microarray hybridization of the fluorescently labeled DNA to 
analyze the methylation level of the enriched segments. Affinity capture methods provide large  
 
 
Fig. 4 Methylation Analysis by DNA Immunoprecipitation (meDIP). a. Genomic DNA is denaturated 
and randomly fragmented using restriction endonucleases. Methylated DNA is isolated using antibodies 
for 5-methylcytosine. b. Input DNA and methylated meDIP-enriched DNA are labeled with Cy5 and 
Cy3 respectively. After microarray hybridization, the signal ratio of meDIP to input DNA is used to 
determine the level of methylation.22 
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scale, relatively high-resolution DNA methylation analysis, however the ssDNA needed for 
antibody recognition can be difficult to generate for CpG rich regions of the DNA.15,22 
The methylated CpG island recovery assay (MIRA or MBDCap) is another affinity based method 
for genome-wide methylation detection. Instead of relying on antibodies, the method utilizes 
methyl-CpG-binding domain proteins, e.g. MBD2, to enrich methylated DNA sequences and 
analyze them on either a microarray platform or by sequencing. The method has a low false 
positive rate and does not require specific restriction sites or antibodies. However, the affinity of 
MBD2 depends on methylation density of CpG islands and thus can generate biased methylation 
levels.23 
 
1.2.3. Bisulfite Genomic Sequencing 
An important advance in methylation profiling came with the introduction of bisulfite sequencing 
by Susan Clark and Marianne Frommer in 1993. Bisulfite genomic sequencing (BGS) is the most 
widely used method of DNA methylation analysis today; however, since 1993 the technology has 
been only slightly improved.24,25 BGS makes use of the ability of sodium bisulfite to convert 
cytosine residues in single-stranded DNA to uracils without converting non-reactive 5-
methylcytosines (5-MeC) (Fig. 5).  
During BGS, DNA is incubated at elevated temperatures in the presence of sodium bisulfite. 
Sodium bisulfite attacks the 5-6 double bond in cytosine; this attack is blocked by methylation (or 
hydroxymethylation) at the 5 position. When the bisulfite ion adds across the 5-6 double bond of 
cytosine, it forms a 6-sulphonate intermediate in a highly single-strand specific reaction. 
Hydrolytic deamination of this intermediate product results in formation of a uracil derivative. At 
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the last step, alkali treatment removes the sulfonate group to generate uracil. Methylated cytosines 
are not converted to uracils since the reaction between 5-MeC and bisulfite is very slow and favors 
formation of 5-MeC rather than the deamination product (Fig. 6). After PCR amplification, 
cytosines that were unmethylated in the starting DNA are sequenced as thymines. 
 
 
Bisulfite sequencing is the accepted standard in methylation profiling, but it has several 
shortcomings usually ignored for the sake of convenience. These can be summarized as the need 
 
Fig. 5 Bisulfite Genomic Sequencing to Detect DNA Methylation.26 Today the gold standard in DNA 
methylation analysis is Bisulfite Genomic Sequencing. In this method, bisulfite converts unmethylated 
Cs in single stranded DNA to Us. The initial strand in the figure has both methylated and unmethylated 
cytosines shown in blue and pink. After treatment with bisulfite, unmethylated cytosines are converted 
to uracils and after PCR amplification are sequenced as thymines whereas methylated cytosines are not 
converted and are sequenced as cytosines. By comparing the sequence information of untreated and 
treated strands, it is possible to obtain the methylation pattern of the initial sequence. 
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for large amounts of starting DNA, strong PCR biases, loss of sequence information upon 
conversion, non-conversion and false positive results.  
 
As the major shortcoming of the method, alkali- and bisulfite-mediated DNA degradation is so 




Fig. 6 Chemical Mechanism of Bisulfite Sequencing. After treatment with bisulfite the sulfonate group 
is added to the 6 position of the cytosine ring. This addition reaction causes the replacement of the 5,6 
double bond with a single bond which makes the amine group very unstable, leading to oxidative 
deamination at this position. As cytosine is converted to a uracil analog, the sulfonate group is removed 
by alkali treatment and the remaining base is uracil. On the other hand, methylcytosines cannot be 
converted by this treatment and they remain unchanged. 
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into fragments of <300 bp27; thus bisulfite sequencing requires relatively large amounts of DNA. 
Second, bisulfite attack at unmethylated cytosines leads to a higher incidence of strand breakage 
at these sequences, which strongly enriches for methylated sequences; the bias can exceed 10-
fold.28 Third, there is an enormous loss of sequence complexity after bisulfite conversion because 
>95% of all cytosines are converted to thymines. Fourth, CpG dinucleotides in some sequence 
contexts are resistant to bisulfite attack and therefore yield false positive methylation data.29 Fifth, 
CpG dinucleotides are underrepresented in the human genome and are strongly concentrated in 
CpG islands; as a result, ~80% of standard Next Generation Sequencing reads from bisulfite-
converted DNA are uninformative because they contain no CpGs. 
The shortcomings of bisulfite sequencing are especially relevant to CpG islands, which are very 
C-rich (resulting in greater loss of sequence complexity) and are normally unmethylated (leading 
to a higher rate of cleavage). This is especially unfortunate as it is the methylation status of CpG 
islands (which cover the promoters of 76% of all protein-coding genes)30 that is of most biological 
interest. 
These drawbacks render conventional BGS inadequate for whole-genome methylation profiling 
by ultrahigh throughput DNA sequencing.27 Major improvements or new approaches overcoming 
the above-mentioned limitations are needed to advance complete (high resolution) genome-wide 
DNA methylation profiling.  
 
1.3. Introduction of the New Method 
The method being proposed in this thesis is a combined enzymatic-photochemical approach suited 
to any current DNA sequencing platform. This novel approach is based on DNA 
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methyltransferase-aided site-specific conversion of unmethylated Cs in CpG dinucleotides (Fig. 
7).  
 
We study this novel approach in two parts. The first part (Chapter 2) will focus on the 
photochemical conversion of the 5 position modified C to a T analog. Haga et al. (1993) showed 
that covalently attached reactive functionalities initiate highly efficient photoinduced 
intramolecular reactions that convert C to a T analog.33 The optimum conversion can be achieved 
using the most suitable photoreactive group and under conditions that produce fast and highly 
efficient photo-conversion with minimal damage to DNA. In Chapter 2, we will discuss a model 
5 position modified deoxycytidine to achieve optimum C to T photo-conversion. Such a 
conversion strategy would overcome the drawbacks in existing methods, therefore advancing the 
 
Fig. 7 DNA Methyltransferase Aided Site-specific Conversion of C to T in Unmethylated CpG 
Sites. DNA methyltransferases are able to transfer a wide variety of functional groups to the 5 position 
of Cs in CpG dinucleotides in double stranded DNA with high sequence specificity.31,32 Shown is the 
transfer of a reactive R group to the 5 position of cytosine. After transfer, a light triggered intramolecular 
reaction between R and the base will facilitate deamination at the 4 position to form a T analog. The R 
group is in the major groove on the opposite side of the base from the atoms involved in hydrogen bond 
formation with the complementary base, and will not interfere with base pairing and polymerase activity. 
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field of genome-wide DNA methylation profiling. 
The third chapter will focus on the enzymatic transfer of photoreactive moieties from S-adenosyl-
L-methionine (AdoMet) analogs to the 5 position of Cs in DNA CpG sites. In the literature, Dalhoff 
et al. (2006) synthesized AdoMet analogs in which the methyl group has been replaced by a variety 
of functional groups.31 They showed that DNA methyltransferases were able to specifically 
transfer these functional groups to the 5 position of Cs in DNA CpG sites with 100% efficiency. 
This study shed light on the possibility of using DNA methyltransferases for sequence-specific, 
covalent attachment of larger chemical groups to DNA. We take advantage of this capacity to use 
CpG site-specific DNA methyltransferases to modify the 5 position of C with suitable reactive 
moieties that can subsequently convert a C to a T analog.34 
At the end, the overall method will be a combination of these two parts. In the first part, AdoMet 
analogs derivatized with a highly efficient C-reactive functionality will be used as substrates of 
DNA methyltransferases to transfer these reactive functionalities to the 5 position of cytosines in 
unmethylated CpG islands. Then under optimized conditions, the modified CpG Cs will be photo-
converted to T analogs. After conversion, PCR amplification and ultrahigh throughput DNA 
sequencing of the converted DNA will provide a single base resolution methylation profile; 
unmethylated cytosines will be sequenced as thymines, while methylated cytosines will be 
sequenced as cytosines (Fig. 8). In this way, the method will unambiguously identify all 





The importance of DNA methylation is becoming clearer as a diverse array of diseases are being 
associated with aberrant DNA methylation. Numerous methods are available for DNA methylation 
analysis yet those methods cannot provide the resolution and sensitivity needed to achieve error 
 
Fig. 8 Overall Scheme for the DNA Methylation Profiling Method based on DNA 
Methyltransferase Aided CpG Site-specific Conversion of C to T.   With this new method, we will 
be able to transfer desired reactive groups from optimized AdoMet analogs to unmethylated cytosines in 
CpG sites using DNA methyltranserases. After photo-irradiation, only modified Cs can be further 
converted to T analogs via a photo-triggered intramolecular reaction. With subsequent amplification and 
sequencing, unmethylated cytosines will be sequenced as thymines and the methylated ones will be 




To make progress in understanding the role of methylation abnormalities in cancer, a new method 
that can determine the methylation status of all CpG dinucleotides in very small amounts of DNA 
is essential. Such a method should convert the C’s in CpG islands with high efficiency, under mild 
conditions and in a site-specific way, and should be adaptable to high throughput next-generation 
DNA sequencing platforms. New chemistry meeting these criteria is pressingly desired to buttress 
or supplant bisulfite sequencing. 
To meet these purposes we are developing a new method that will identify the methylation status 
of CpG sites. This approach is expected to display great increases in accuracy, economy, 
sensitivity, and throughput compared to extant methods. The appreciation of the importance of 
epigenetic effects in human health, disease, and transgenerational inheritance demands the 
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Chapter 2. Photochemical Conversion of Cytosine to Thymine 
2.1. Abstract 
To study photochemical conversion of cytosine to thymine, we have synthesized two model 
deoxycytidine molecules, 5-Allyl-dC and PhAll-dC. 5-Allyl-dC contains an allyl group and PhAll-
dC contains a cinnamyl ether (phenylallyl) group at the 5 position of cytosine. It was demonstrated 
that these molecules undergo photo-conversion to deoxythymidine analogs upon UV irradiation 
(300 – 320 nm), as assessed by MS and NMR. Furthermore, in the case of PhAll-dC, the triplet 
photosensitizer thioxanthone (TX) was used to shift the irradiation to longer wavelengths (350 – 
400 nm) to prevent any potential damage to DNA. 
 
2.2. Introduction 
Conversion chemistries specific to unmethylated cytosines have found intensive applications in 
DNA methylation profiling to distinguish methylated and unmethylated Cs in the genome. Due to 
the drawbacks of bisulfite conversion for methylation profiling, more specific and efficient C to T 
(U) conversion chemistries are highly desirable. It is well known that nitrous acid or alkyl nitrite 
can convert C to T. If such a group is localized at the 5 position of C, it could specifically convert 
5 position nitrite-modified C to a T analog without affecting the unmodified Cs in DNA. Our lab 
has previously proposed a mechanism where alkyl nitrite is transferred to the 5 position of C, then 
a diazonium cation could be generated and further nucleophilic attack at C4 forms the 4-carbonyl 





In an alternative mechanism, photo-irradiation induced C to T conversion chemistry is feasible via 
a [2+2] photocycloaddition (Fig. 10) and can be further exploited for use in our proposed 
methylation profiling method. In this conversion mechanism, photo-irradiation generates a 5,6-
cyclobutane intermediate between an alkene and the 5,6 double bond of C via a [2+2] 
photocycloaddition. This leads to the interruption of the conjugated system in C and produces a 
5,6-cyclobutane intermediate between an alkene and the 5,6 position double bond.  Due to the 
interruption of the conjugated system, further deamination at the 4 position can readily occur 
resulting in formation of a U derivative.33 This chemistry has been applied to on-DNA conversion 
of C to U, in which a double bond containing U is positioned in close proximity to C with the aid 





Fig. 9 Mechanism for C to T Conversion via Oxidative Deamination. Cytosine analog with an alkyl 
nitrite at the 5 position undergoes oxidative deamination. First a diazonium cation is generated, then this 




These different conversion chemistries demonstrate options to convert C to T. In order to achieve 
this goal, our work explores the feasibility of [2+2] photocycloaddition to mediate site-specific C 
to T conversion on DNA following DNA methyltransferase aided modification of the 5 position 
of C with a chemical moiety. The major challenges of this process lie in finding a suitable double 
bond containing moiety that can be efficiently attached to the 5 position of C and subsequently 
readily interact with the 5-6 double bond of C. This [2+2] photocycloaddition leads to the 
formation of a cyclobutane intermediate and is followed by deamination to generate a U analog. 
Lastly, this chemical moiety needs to be suitable to linking to AdoMet and this AdoMet analog 
needs to be compatible with DNA methyltransferase to be transferred to unmethylated cytosines. 
Since such an example has never been reported, we start our research with the design and synthesis 
 
Fig. 10 Photo-conversion of Cytosine to Uracil via [2+2] Photocycloaddition.33 There are existing 
chemistries other than bisulfite conversion that can convert C into U. When a double bond is present in 
the vicinity of the 5,6 double bond of the cytosine ring, upon photo-irradiation a [2+2] photocycloaddition 
takes place in which both double bonds become saturated. In this way, the conjugated system of the 
cytosine ring is interrupted and the 4 position amine group becomes very unstable. As a result, 
deamination occurs at the 4 position and the molecule converts to a U analog. 
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of 5 position derivatized model deoxycytidines and test their photo-conversion to T analogs to 
screen and validate suitable photoreactive groups. 
 
2.3. Results and Discussion 
2.3.1 Model Compound 5-Allyl-dC (5-Allyloxymethyl-Deoxycytidine)* 
2.3.1.1. Design and Synthesis of 5-Allyl-dC 
 
2.3.1.2. Analysis and Proof of Photo-conversion of 5-Allyl-dC 
5-Allyl-dC was irradiated in a Rayonet reactor with UVB light (300 nm) in deoxygenated water 
for up to 12 hours. The photoproduct was isolated by HPLC and characterized by MS and UV 
absorption spectroscopy. The analyses showed that after photo-irradiation 5-allyl-dC was 
photochemically converted to a new product. The new photoproduct was characterized as 5-
allyloxymethyl-deoxythymidine (5-allyl-dT) proving C to T conversion (Fig. 13). 
                                                          
*Experiments with 5-Allyl-dC was conducted by Dr. Xiaoxu Li and Dr. Shiv Kumar.  
The first model compound synthesized and studied for photo-
conversion was 5-allyloxymethyl-deoxycytditine (5-allyl-dC) 
(Fig. 11). 5-Allyl-dC is designed by inserting a double bond three 
carbon units away from the 5 position. The synthesis scheme for 
the compound is given in Fig. 12. After synthesis the product was 





The reaction solution was analyzed by HPLC after 3 and 12 hours of photo-irradiation. The HPLC 
profiles indicated the conversion of the starting material into a new photoproduct (Fig. 14). The 
MS and UV absorption spectra showed that the photoproduct had a molecular weight of 299 g/mol 
(calculated 298 g/mol) and absorbed at 265 nm, respectively, whereas the starting material had a 
molecular weight of 298 g/mol (cal. 297 g/mol) with an absorption max at 274 nm (Fig. 15). These 
results confirmed that the newly formed photoproduct is 5-allyl-dT, the thymidine derivative of 
our starting material. 
 
Fig. 12 Synthesis Scheme for Model Compound 5-Allyl-dC. In the first step of synthesis, the two 
hydroxyl groups of deoxythymidine were protected and this was followed by bromination at the 5-methyl 
group. In the presence of allyl alcohol, a further substitution reaction led to an allyl ether intermediate. 




Fig. 13 Photochemical Conversion of 5-Allyl-dC to 5-Allyl-dT. Deoxycytidine was modified at the 5 
position with an allyloxymethyl group. After 12h of photo-irradiation at 300 nm, the starting molecule 
has converted to a new photoproduct, 5-allyl-dT.  
 
Fig. 14 HPLC Analysis of Photo-
conversion Reaction. 5-Allyl-dC was 
subjected to 300 nm photo-irradiation for up 
to 12 hours. The top figure is the HPLC 
profile of the reaction mixture after 3 hours. 
The bottom profile was obtained after 12 
hours of reaction and shows that the starting 
material (5-allyl-dC) is mostly consumed. 
The molecular weight of the photoproduct 
was determined to be one unit (g/mol) higher 
than 5-allyl-dC matching the molecular 






Fig. 15 UV Absorption Maxima for 5-Allyl-dC and Photoproduct. The UV spectra of the starting 
material and the photoproduct showed that while 5-allyl-dC absorbed at 275 nm, the absorption maxima 
of the new photoproduct shifted to 265 nm which is characteristic of T. 
 
2.3.1.3. Photo-conversion of 5-Allyl-dC to a T Analog on DNA 
After proving photo-conversion in solution, the next step was performed to test conversion on a 
DNA strand. For this experiment, a fully protected 5-allyl-dC phosphoramidite (C*) was 
synthesized and incorporated into the 16mer oligonucleotide, 5’-TACGA(C*)GAGTGCGGCA-
3’, via standard oligonucleotide synthesis. After HPLC purification, the modified 16mer was 
characterized by MALDI TOF MS yielding a peak at 5001, equal to the calculated mass. Then the 
oligonucleotide was photo-irradiated to convert the incorporated C* to a T analog. The outcome 
for conversion of C* on DNA was detected by single base extension MS analysis (Fig. 16). In this 
analysis, the photo-irradiated oligonucleotide was annealed with a primer, 5'-TGCCGCACTC-3' 
(MW 2964), and incubated with ddNTPs and DNA polymerase. With the aid of DNA polymerase, 
one of the 4 ddNTPs can be selectively incorporated onto the 3' end of the primer. Photochemistry 
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induced conversion of C to T should be able to direct the incorporation of ddA, resulting in an 
elongated primer with a MW of 3261; in the case of no conversion, ddG would be incorporated 
giving an elongated primer of MW 3277. Actual MS measurement of the single base extended 
primer showed the MW as 3273 (within the error range of the instrument) which matched the MW 
of the primer incorporated with a single ddATP. Extension with ddATP confirms the existence of 
a complementary T on the template and demonstrates the photochemical conversion of C* to a T 
analog on DNA. In the control experiment, the unmodified counterpart, 5'-
TACGACGAGTGCGGCA-3', was photo-irradiated under the same conditions. The single base 
extension MS analysis of the extended primer gave a MW of 3288 (within the error range of the 
instrument) which matched the MW of the primer extended with a single ddGTP.  
The above studies show that 5 position modification of C with a photoreactive moiety provides us 
with a new route for efficient C to T conversion, demonstrating the feasibility of CpG site-specific 
conversion of C to T without the drawbacks of bisulfite conversion. In order to improve our photo-
conversion chemistry further, we have designed and synthesized a new model compound, PhAll-
dC, which we will discuss in the rest of this chapter.  
 
2.3.2. Model Compound PhAll-dC (5-Cinnamyloxymethyl-Deoxycytidine) 
2.3.2.1. Design and Synthesis of PhAll-dC*  
We have demonstrated that a C with its 5 position modified with an alkene-bearing chemical group 
can be photo-converted to a T analog by 300 nm photo-irradiation using the model compound        
                                                          
* PhAll-dC was synthesized by Dr. Xiaoxu Li and Dr. Xin Chen. 
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5-allyl-dC. Due to likely damaging effects of UVB radiation (⁓300 nm) on DNA, further chemical 
modifications at the photoreactive double bond were proposed to extend the conjugation system. 
In this way, longer wavelength of light (≥350 nm) can be used for irradiation resulting in 
photocycloaddition and oxidative deamination.  
 
 
Fig. 16 Site-specific Photochemical Conversion of C to T Analog on DNA. Left: The 16mer 
containing a C*pG site (C* = 5-allyl-dC) was subjected to 300 nm (7 h) irradiation and then was annealed 
to a primer of known mass for single base extension. The molecular weight of the extended primer was 
determined by MALDI TOF MS. The result shows that the primer was elongated by ddA.  Right: When 
the same procedure was repeated with an unmodified CpG site in the 16mer, the MS analysis showed 
that the primer was elongated by ddG during single base extension. These results prove C* was photo-
converted into thymine while C remained intact. 
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Considering the distance between the modified double bond and the 5,6 double bond of C for 
favorable intramolecular photocycloaddition, we synthesized a cinnamyl ether derivative of 
cytidine (PhAll-dC) so that a longer, DNA-benign wavelength could be used to trigger C to T 
conversion. The synthesis route for the compound is given in Fig. 17. The synthesized compound 





Fig. 17 Synthesis Scheme for Model Compound PhAll-dC. In the first step of synthesis, the two 
hydroxyl groups of deoxythymidine were protected and this was followed by bromination at the 5-methyl 
group. The oxygen in cinnamyl alcohol attacks the 5 position carbon after which the bromide leaves and 
an ether bond forms. Lastly, uracil is converted to cytosine in a 2 step reaction and fluoride is used to 
remove the silane protective groups. 
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2.3.2.2. Direct Photo-irradiation of PhAll-dC 
PhAll-dC was irradiated with light in the 300-400 nm range in a Rayonet reactor for 4 hours. The 
HPLC profiles of the reaction mixture before and after photo-irradiation are given in Fig. 18.  
 
 
During the course of the reaction the starting material, PhAll-dC, converted to new photoproducts. 
The major fraction at 27 min retention time was isolated and analyzed by mass spectrometry. The 
 
Fig. 18 HPLC Analysis of Direct Photo-irradiation of PhAll-dC. Top: PhAll-dC before photo-
irradiation. Bottom: Analysis after 4h photo-irradiation with 300 – 400 nm light. 
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molar mass of the isolated photoproduct was found to be 374.5 g/mol, matching the molecular 
weight of the expected photoproduct of the reaction, PhAll-dT.  
  
2.3.2.3. Use of Absorbance and Fluorescence to Study Excited State Properties*  
Fig. 19A shows the absorption spectrum of PhAll-dC which is dominated by the overlap of two 
independent chromophores, the cinnamyl ether and the cytosine chromophore.  Photoexcitation 
can generate singlet excited states of both chromophores.  Fluorescence measurements were 
performed to investigate the singlet excited state reactivity (Fig. 19B).  Practically no fluorescence 
was observed after photoexcitation of PhAll-dC.  However, when the cinnamyl chromophore was 
excited independently, using cinnamyl alcohol as a model chromophore, strong fluorescence was 
observed.  The lack of fluorescence from the cinnamyl ether chromophore in PhAll-dC could be  
                                                          
* Conducted by Dr. Steffen Jockusch. 
 
Fig. 19 A: Absorption Spectrum of PhAll-dC in Acetonitrile.  B: Fluorescence Spectra of PhAll-dC 
(Blue-Green) and PhAll-OH (Blue) in Acetonitrile Solution (Excitation Wavelength: 282 nm).   
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caused by efficient intramolecular energy transfer from the cinnamyl to the cytosine chromophore 
which is energetically favorable (singlet excited state energies for cinnamyl alcohol S1 = 407 
kJ/mol and cytosine S1 = 403 kJ/mol).   
The singlet excited states generated by photoexcitation can undergo intersystem crossing into 
triplet states. Because of their longer lifetimes, triplet states often react more efficiently than singlet 
excited states. The triplet energy of the cinnamyl ether chromophore (T1 = 260 kJ/mol) is lower 
than the triplet energy of the cytosine chromophore (T1 = 334 kJ/mol).  Therefore, triplet energy 
transfer can occur from the cytosine chromophore to the cinnamyl ether chromophore, but not 
from the cinnamyl ether chromophore to the cytosine chromophore (Fig. 20).    
 
 
Fig. 20 State Energy Diagram of the Chromophores in PhAll-dC. Singlet and triplet state energies of 
cinnamyl alcohol and deoxycytidine were used as models for the two chromophores in PhAll-dC. 
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These results indicate that direct photolysis of PhAll-dC can take place with both chromophores 
in the molecule absorbing in addition to intramolecular energy transfer. For direct photolysis of 
PhAll-dC, light around 300 nm or shorter is required which is harmful to DNA.  To shift the 
irradiation to longer wavelengths into a DNA benign spectral region, triplet sensitization was 
performed as discussed in the next section.    
 
2.3.2.4. Triplet Photosensitizer Thioxanthone* 
Triplet photosensitizers are often used as catalysts in photochemical reactions. The triplet 
sensitizer absorbs light and efficiently intersystem crosses into the triplet state after which it 
transfers the triplet energy to compounds with low intrinsic triplet state yields.38 The properties of 
a good triplet sensitizer are: (i) high extinction coefficient for efficient light absorption, (ii) high 
triplet quantum yield, (iii) high enough triplet energy and (iv) a long triplet lifetime with no side 
reactions.  The triplet energy of the triplet sensitizer must be higher than the triplet energy of the 
acceptor.   
For our purposes, a suitable triplet sensitizer should have a triplet energy of higher than 260 kJ/mol 
and should absorb light in the DNA benign spectral region, above 350 nm.  Thioxanthone (TX) 
emerged as the ideal candidate. As shown in Fig. 21, TX absorbs strongly at ~380 nm with an 
extinction coefficient of ~ 6500 M-1cm-1 and has a triplet energy of 269 kJ/mol. 
The mechanism for the triplet energy transfer from the photosensitizer, TX, to PhAll-dC is given 
in Fig 22. Photoexcitation of TX leads to singlet excited states which undergo efficient intersystem  
                                                          




crosses into the triplet states with quantum yields of 0.6 to 0.8.39 Because the triplet energy of TX 
(269 kJ/mol) is higher than for the cinnamyl chromophore of PhAll-dC (260 kJ/mol) but lower 
than the triplet energy of the cytosine chromophore (334 kJ/mol), TX transfers its triplet energy to 
the cinnamyl chromophore but not to the cytosine chromophore. The generated triplet states of 
cinnamyl can initiate the [2+2] photocycloaddition. 
To examine this difference in sensitization experimentally, the bimolecular rate constants for 
quenching of TX triplet states by these two chromophores were determined by laser flash 
photolysis using cinnamyl alcohol and dC as model compounds for the two chromophores. After 
pulsed laser excitation at 355 nm, TX shows a strong triplet absorption at 625 nm40 with a lifetime 








Triplet absorption decay traces were recorded at 625 nm in the absence and presence of different 
concentrations of quenchers (cinnamyl alcohol and dC) as shown in Fig. 23 (left).  These decay 
traces were fit to a monoexponential function to obtain the pseudo-first order quenching rate 
constants.  The slope of the plot of the pseudo-first order quenching kinetics against the various 
quencher concentrations yielded rate constants for TX triplet quenching by cinnamyl alcohol and 
dC of 7.8  109 M-1s-1 and 0.2  109 M-1s-1, respectively (Fig. 23, right).  The high rate constant for 
the cinnamyl chromophore is close to the theoretical maximum rate constant for triplet energy 
transfer confirming that TX is ideally suited as a sensitizer for PhAll-dC. The generated triplet 
states of the cinnamyl chromophore of PhAll-dC undergo efficient [2+2] photocycloaddition (Fig. 
 
Fig. 22 Triplet Energy Transfer between TX and PhAll-dC. Upon absorption of light between 350 – 
400 nm, TX is excited and undergoes intersystem crossing to a triplet state. Then it transfers its triplet 
energy to the cinnamyl chromophore generating the cinnamyl triplet excited state.  
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22). At the same time, the 40 times lower rate constant for dC will greatly reduce unwanted side 
reactions.      
 
 
2.3.2.5. Photochemical Conversion of Cinnamyl Derivative of Cytidine 
PhAll-dC was irradiated with 350 nm light in a Rayonet reactor in the presence of TX. The HPLC 
profiles of the reaction mixture before and after photo-irradiation are given in Fig. 24. While the 
concentration of the sensitizer (TX) remained unchanged during the course of the reaction, over 
 
Fig. 23 Transient Absorption Spectroscopy and Laser Flash Photolysis. Left: Decay traces of the 
transient absorbance of the TX triplet monitored at 625 nm after pulsed laser excitation (355 nm, 5 ns 
pulse width) in argon saturated acetonitrile solutions in the absence and presence of various 
concentrations of cinnamyl alcohol (0 to 0.25 mM). Right: Determination of the triplet quenching rate 
constant from the slope of the plot of the pseudo-first order rate constant of the decay of the TX triplet at 
various concentrations of cinnamyl alcohol and dC. 
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70% of PhAll-dC converted to new photoproducts after 20 min irradiation. The major fraction at 
~26 min retention time was isolated and analyzed by mass spectrometry, infrared spectroscopy 
(FT-IR) (Fig. 25), 1H-NMR (Fig. 26) and 13C-NMR (Fig. 27).  Consistent with these analytical 
data, this photoproduct was identified as a cyclobutyl derivative of dT, either as the straight or 
cross adduct, as shown in orange at the bottom of Fig. 24.  Under these mild photolysis conditions, 
the cyclobutyl derivative of dT is the stable reaction product. 
 
Fig. 24 HPLC Analysis of PhAll-dC Photoreaction. Top: PhAll-dC (shown in blue-green at top center) 
in the presence of the triplet sensitizer thioxanthone (TX; shown in red at top right) before photo-
irradiation. Bottom: Analysis after 20 min photo-irradiation with 350 nm light. 
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The detailed mechanism of the transformation of PhAll-dC to a dT analog is shown in Fig. 28. 
With the absorption of light, TX goes from the singlet ground state to the singlet excited state. 
Then through intersystem crossing it transitions to the triplet state and transfers its triplet energy 
to the cinnamyl chromophore of PhAll-dC. The generated triplet excited states of the cinnamyl 
chromophore enables the [2+2] photocycloaddition reaction. 
 
Photocycloaddition may take place either in the straight form or as a cross-adduct as shown in Fig. 
28. Following photocycloaddition, the primary amine group in the cytosine moiety is oxidized to 
a carbonyl group. This reaction occurs spontaneously in aqueous solution (pH 7) due to loss of the  
                                                          
* FT-IR analysis was conducted by Dr. Steffen Jockusch.  
 
Fig. 25 FT-IR Analysis in the Carbonyl Spectral Region of dC, PhAll-dC, dU and the 
Photoproduct.* The shift of the photoproducts (blue) to higher energies is compared to dC (green) and 




5,6-double bond in cytosine.  In the final step, cycloreversion would generate PhAll-dT. 
Cycloreversion of a similar dT derivative has been reported in the literature36,37 and was observed 
in our laboratory. 
Although the cyclobutyl derivatives we generated in TX-sensitized photo-conversion of PhAll-dC 
vary from the canonical base T, they bear all of the base pairing features of T and should be 
complementary to dA. 
                                                          
* 1H-NMR analysis was conducted by Dr. Xiaoxu Li. 
 
Fig. 26 1H-NMR Analysis of PhAll-dC (Top) and Isolated Photoproduct (Bottom).* 1H-NMR spectra 
indicate the loss of the 5,6 double bond and b,c double bond in the photoproduct. The 4 position amino 




These results show that first generation photoactive groups can induce nearly full conversion of 




                                                          
* 13C-NMR analysis was conducted by Dr. Xiaoxu Li.  
 
Fig. 27 13C-NMR Analysis of PhAll-dC (Top) and Isolated Photoproduct (Bottom).* Major shifts 
were observed for carbon atoms 5, 6, c, and d (marked in red). For simplicity, only the straight [2+2] 




2.4. Materials and Methods 
1H-NMR and 13C-NMR spectra were recorded on Bruker 300 or 400 MHz and Bruker 75 or 100 
MHz spectrometers respectively and reported as shifts in ppm from a methanol-d4, chloroform-d 
or DMSO-d6 internal standard (3.31, 7.26 and 2.50 ppm respectively for 
1H NMR and 49.86, 77.36 
and 39.51 ppm respectively for 13C-NMR). Data were reported as follows: (s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet, dd = doublet of doublets; coupling constant(s) in Hz). Mass 
spectra (MS) were obtained on an Advion Mass Spec mass spectrometer equipped with both 
electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) probes. Mass 
measurement of DNA was performed on a Voyager DE MALDI TOF mass spectrometer (Applied 
Biosystems). HPLC was used to purify the DNA oligonucleotides (C‐18 reverse phase column, 
elution gradient: B 0% in A to 50% in 40 min, A: HFIP‐TEA buffer, B: Methanol). Nucleosides 
 
Fig. 28 Photochemical Conversion of PhAll-dC to PhAll-dT. (1) Direct photolysis or triplet 
sensitization initiates a [2+2] photocycloaddition. (2) The primary amine group of dC is converted to a 






















































were purchased from TCI and ChemGene. All other chemicals were purchased from Sigma-
Aldrich.  
 
2.4.1. Model Compound 5-Allyl-dC 
2.4.1.1. Synthesis of 5-Allyl-dC 
3'-5'-Bis-O-(tert-Butyldimethylsilyl)-5-Bromomethyl-Deoxyuridine  
To a solution of 3'-5'-bis-O-(tert-butyldimethylsilyl)-thymidine (1 g, 2.124 mmol) in 100 ml 
benzene, 2,2'-azobisisobutyronitrile (AIBN) (10 mg, 0.03 eq.) and N-bromosuccinimide (NBS) 
(654 mg, 3.67 mmol, 1.7 eq.) were added, then the mixture was heated under reflux for 4 h. After 
cooling to room temperature, the reaction mixture was concentrated to dryness under reduced 
pressure and the residue was purified by silica gel column chromatography (ethyl acetate/hexane: 
1/5-1/3) to give pure product (0.862 g, 74%). 1H-NMR (300 MHz, CDCl3) δ: 8.80 (s, 1H), 7.88 (s, 
1H), 6.29 (t, 1H), 4.40 (m, 1H), 4.23 (q, 2H), 3.98 (d, 1H), 3.91-3.75 (dd, 2H), 2.36-2.28 (m, 1H), 
2.05-1.96 (m, 1H),  0.95-0.89 (m, 18H),  0.14-0.08 (m, 12H)). 13C-NMR (75 MHz, CD3OD) δ 
161.83, 150.08, 139.61, 112.11, 85.61, 85.95, 72.68, 63.44, 41.25, 26.39, 26.14, 25.48, (-4.24)-(-
5.25); APCI-MS: calculated for C22H42BrN2O5Si2 [(M+H)
+]: 549.17, found: 549.30 and 551.29.   
 
3'-5'-Bis-O-(tert-Butyldimethylsilyl)-5-Allyloxymethyl-Deoxyuridine  
3'-5'-bis-O-(tert-butyldimethylsilyl)-5-bromomethylthymidine (170 mg, 0.31 mmol) was 
dissolved in DCM (15 ml), and TEA (1.078 ml, 25 eq.) and allyl alcohol (7.39 ml, 35 eq.) were 
added. The reaction mixture was heated under reflux for 48 h. The reaction mixture was 
concentrated to dryness under reduced pressure and the residue was purified by silica gel column 
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chromatography (ethyl acetate/hexane: 1/5-1/3) to give pure product (150 mg, 91.8%). 1H-NMR 
(300 MHz, CDCl3) δ: 8.54 (s, 1H), 7.66 (s, 1H), 6.32 (t, 1H), 5.94 (m, 1H), 5.34 (d, 1H), 5.23 (d, 
1H), 4.43 (m, 1H), 4.27 (q, 2H), 4.08 (d, 2H), 3.96 (m, 1H),  3.81 (m, 2H), 2.30-2.28 (m, 1H), 
2.07-2.03 (m, 1H); 0.95-0.91 (m, 18H); 0.13-0.09 (m, 12H). 13C-NMR (75 MHz, CDCl3) δ 162.12, 
149.75, 137.86, 134.20, 117.31, 111.61, 87.70, 85.07, 72.10, 71.72, 64.11, 62.82, 41.20, 25.77, 
25.56, (-4.85)-(-5.66); APCI-MS: calculated for C25H47N2O6Si2 [(M+H)
+]: 527.29, found: 527.67. 
 
3'-5'-Bis-O-(tert-Butyldimethylsilyl)-5-Allyloxymethyl-Deoxycytidine  
1,2,4-triazole (393.5 mg, 5.7 mmol, 20 eq.) was suspended in acetonitrile (ACN) (8 ml), 
phosphoryl chloride (P(O)Cl3) (109.2 mg, 65.2 µl, 0.712 mmol, 2.5 eq.) was added dropwise and 
the mixture was stirred at 0°C for 10 min. After addition of TEA (633.3 mg, 872 µl, 6.27 mmol, 
22 eq.) over 3 min, the mixture was stirred for a further 20 min, then the solution of 3'-5'-bis-O-
(tert-butyldimethylsilyl)-5-allyloxymethyl-deoxyuridine (150 mg, 0.285 mmol) in ACN (5 ml) 
was added, and the reaction solution was stirred at r.t. for 1 h. Then TEA (233 µl) and H2O (61 µl) 
were added and the mixture was stirred for 10 min. The reaction mixture was concentrated to 
dryness under reduced pressure.  To the residue 1,4-dioxane (5 ml) and concentrated ammonium 
hydroxide (NH4OH) (3 ml) were added and the mixture was stirred for 1h. The reaction mixture 
was again concentrated to dryness under reduced pressure, acetyl acetate was added to dissolve 
the residue and the organic phase was washed with brine (3×40 ml). The organic phase was 
concentrated to dryness and the residue was purified by silica gel column chromatography (ethyl 
acetate) to give pure product (80.8 mg, 54%). 1H-NMR (300 MHz, CDCl3) δ: 8.37 (s, 1H), 6.13 
(d, 1H), 5.94-5.8 4 (m, 1H), 5.32 (dd, 1H), 5.22 (dd, 1H),4.65 (q,1H), 4.34 (q, 2H), 4.20 (d,1H), 
41 
 
3.96 (d, 2H), 3.76 (m, 2H), 2.42-2.37 (m, 1H), 2.24-2.17 (m, 1H); 0.95-0.91 (m, 18H); 0.13-0.09 
(m, 12H). APCI-MS: calculated for C25H48N3O5Si2 [(M+H)
+]: 526.31, found: 526.79. 
 
5-Allyloxymethyl-Deoxycytidine 
3'-5'-bis-O-(tert-butyldimethylsilyl)-5-allyloxymethyl-deoxycytidine (80 mg, 0.152 mmol) was 
dissolved in THF (4 ml) and TBAF solution (1 M in THF) (0.61 ml, 4 eq.) was added while stirring. 
The reaction mixture was stirred for 2 h, and the solvent was removed under reduced pressure. The 
residue was subjected to silica gel column chromatography purification (DCM/MeOH  6/1-3/1) to 
yield pure product (42 mg, 93%). 1H-NMR (300 MHz, MeOD) δ: 8.11 (s, 1H), 6.26 (t, 1H), 5.95 
(m, 1H), 5.29 (d, 1H), 5.22 (d, 1H), 4.39 (m, 1H), 4.33 (s, 2H), 4.03 (dd, 2H), 3.95  (m, 1H), 3.86-
3.74 (m, 2H), 2.42-2.36 (m, 1H), 2.20-2.13 (m, 1H); 13C-NMR (75 MHz, CDCl3) δ 165.63, 157.05, 
141.32, 134.62, 116.76, 103.76, 87.88, 86.57, 70.73, 70.67, 66.20, 61.57, 41.20;  
APCI-MS: calculated for C13H20N3O5 [(M+H)+]: 298.13, found: 298.32. 
 
2.4.2. Model Compound PhAll-dC 
2.4.2.1. Synthesis of PhAll-dC 
3'-5'-Bis-O-(tert-Butyldimethylsilyl)-5-Cinnamyloxymethyl-Deoxyuridine  
To a solution of cinnamyl alcohol (91.8 mg, 0.6843 mmol, 1.5 eq.) in anhydrous THF (5 ml)  NaH 
(16 mg) was added and the mixture was stirred for 0.5 h. Then the mixture was added dropwise 
into a solution of 3'-5'-bis-O-(tert-butyldimethylsilyl)-5-bromomethyuridine (250 mg, 0.456 
mmol) dropwise. The reaction mixture was stirred at r.t. for 16 h, then concentrated to dryness 
under reduced pressure. The residue was dissolved in DCM (2 ml) and was purified by silica gel 
column chromatography (DCM to elute unreacted starting material, cinnamyl alcohol, followed 
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by elution with ethyl acetate/hexane: 1/3-1/2) to yield the pure product (136 mg, 49.6%). 1H-NMR 
(400 MHz, CDCl3) δ: 8.20 (s, 1H), 7.68 (s, 1H), 7.47-7.31 (m, 5H), 6.65 (d,1H), 6.33 (m,1H), 6.27 
(t, 1H), 4.42 (m, 1H), 4.27 (s, 2H), 4.21 (t, 2H), 3.85 (m, 1H), 3.79-3.76 (m, 2H), 2.31-2.23 (m, 
1H), 2.04-2.00 (m, 1H); 0.90 (s, 18H), 0.08 (s, 12H); 13C-NMR (75 MHz, CDCl3) δ 162.75, 150.34, 
138.65, 136.98, 135.87, 133.42, 128.91,128.13, 126.92, 126.00, 112.19, 88.30, 85.67, 72.65, 
72.04, 64.78, 63.37, 41.77,  26.33,  26.13,  (-4.27)-(-5.11); APCI-MS: calculated for  
C31H51N2O6Si2 [(M+H)
+]: 603.32, found: 603.50. 
 
3'-5'-Bis-O-(tert-Butyldimethylsilyl)-5-Cinnamyloxymethyl-Deoxycytidine 
1,2,4-triazole (312 mg, 453 mmol, 20 eq.) was suspended in acetonitrile (ACN) (8 ml), phosphoryl 
chloride (P(O)Cl3)  (86.7 mg, 51.8 µl, 0.5655 mmol, 2.5 eq.) was added dropwise and the mixture 
was stirred at 0°C for 10 min. After addition of TEA (502.6 mg, 692 µl, 4.98 mmol., 22 eq.) over 
3 min, the mixture was stirred for a further 20 min, then the solution of 3'-5'-bis-O-(tert-
butyldimethylsilyl)-5-cinnamyloxymethyl-deoxyuridine  (136 mg, 0.226 mmol) in ACN (5 ml) 
was added.  The reaction solution was stirred at r.t. for 1 h, then TEA (184.7 µl) and H2O (48.6 ul) 
were added and the mixture was stirred for 10 min. The mixture reaction was concentrated to 
dryness under reduced pressure. To the residue 1,4-dioxane (5 ml) and concentrated ammonium 
hydroxide (NH4OH) (3 ml) were added and the mixture was stirred for 1 h. The reaction mixture 
was concentrated again to dryness under reduced pressure, acetyl acetate was added to dissolve 
the residue and the organic phase was washed with brine (3×40 ml). The organic phase was 
concentrated to dryness and the residue was purified by silica gel column chromatography (ethyl 
acetate) to give pure product (84.1 mg, 62%). 1H-NMR (400 MHz, CDCl3) δ: 7.75 (s, 1H), 7.41-
7.28 (m, 5H), 6.65 (d,1H), 6.33 (m,1H), 6.25 (t, 1H), 4.36 (m, 1H), 4.34 (s, 2H), 4.16 (t, 2H), 3.95 
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(m, 1H), 3.77-3.72 (q, d, 2H), 2.49-2.42 (m, 1H), 2.02-1.93 (m, 1H); 0.90 (s, 18H), 0.08 (s, 12H); 
APCI-MS: calculated  for  C31H52N3O5Si2 [(M+H)
+]: 602.34, found: 602.73.  
 
5-Cinnamyloxymethyl-Deoxycytidine  
3'-5'-bis-O-(tert-butyldimethylsilyl)-5-cinnamyloxymethyl-deoxycytidine (84 mg, 0.140 mmol) 
was dissolved in THF (4 ml), and TBAF solution (1 M in THF) (0.56 ml, 4 eq.) was added while 
stirring. The reaction mixture was stirred for 2 h, and the solvent was removed under reduced 
pressure. The residue was subjected to silica gel column chromatography purification 
(DCM/MeOH 10/1-4/1) to yield pure title product (45.9 mg, 88%). 1H-NMR (300 MHz, DMSO-
d6) δ 7 .88 (s, 1H), 7.46 – 7.22 (m, 6H), 6.64  (s, 1H), 6.59 (s,1H), 6.42 – 6.33 (m, 1H), 6.15 (t, J 
= 6.6 Hz, 1H), 5.18 (d, J = 4.2 Hz, 1H), 4.99 (t, J = 5.3 Hz, 1H), 4.28-4.24 (m and s, 3H), 4.12 (d, 
J = 3.7 Hz, 2H), 3.78 (q, J = 3.7 Hz, 1H), 3.57 (m, J = 5.1 Hz, 2H), 2.22 – 2.06 (m, 1H), 2.02 – 
1.93 (m, 1H); 13C-NMR (75 MHz, CDCl3) δ 165.33, 155.70, 141.78, 137.31, 132.23, 129.45, 
128.45, 127.35, 127.18, 103.10, 88.11, 85.76, 71.13, 70.40, 66.57, 62.15, 41.26; APCI-MS: 
calculated  for  C19H24N3O5 [(M+H)
+]: 374.41, found: 374.75.    
 
2.4.2.2. Spectroscopy 
UV-vis spectra were recorded on an Agilent 8453 spectrometer. Fluorescence spectra were 
recorded on a Fluorolog-3 fluorometer (HORIBA Jobin Yvon).  
Laser flash photolysis experiments employed the pulses from a Spectra Physics GCR-150-30 
Nd:YAG laser (355 nm, 5 ns pulse width) and a computer-controlled system as described 
previously.41 Solutions of the sensitizer (TX) were prepared at a concentration such that the 
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absorbance was 0.3 at the excitation wavelength (355 nm) and deoxygenated by purging with 
argon for 20 minutes.   
IR spectra were recorded on a Nexus 870 FT-IR spectrometer (Nicolet) on CaF2 disks drop-cast 
from CHCl3. 
 
2.4.2.3. Preparation of Reaction Mixtures 
Synthesized PhAll-dC was double purified using RP-HPLC (Waters) with a 15 cm x 4.6 mm, 3 
µM silica-C18 column. The molecule was then dissolved in 65% ACN solution with the final 
concentration of PhAll-dC being 3 mM. For the photosensitized reaction, the concentration of 
thioxanthone (Sigma Aldrich) was 100 µM. The solutions were placed in Kimble KIMAX 
borosilicate glass culture tubes (75x10 mm) with silicone caps and deoxygenated through a thin 
needle with Ar gas for 20 minutes. 
 
2.4.2.4. Photo-irradiation and Analysis 
For direct photo-irradiation of PhAll-dC, deoxygenated PhAll-dC solution was placed in a Rayonet 
reactor (Southern New England Ultraviolet Co.) equipped with 12 mercury lamps with 300 – 400 
nm emission range. The sample was then photo-irradiated at room temperature for 4 hours. The 
chromatographic analysis was done using RP-HPLC (Waters) using a 15 cm x 4.6 mm, 3 µM 
silica-C18 column, with samples taken before and after photo-irradiation for comparison. The 
molecular weight of the new product was determined using APCI mass spectrometry.  
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For the reaction with photosensitizer, deoxygenated PhAll-dC solution was placed in a Rayonet 
reactor (Southern New England Ultraviolet Co.) equipped with 12 mercury lamps with emission 
maximum at 350 nm. The sample was then photo-irradiated at room temperature for 20 minutes. 
The chromatographic analysis was done using RP-HPLC (Waters) using a 15 cm x 4.6 mm, 3 µM 
silica-C18 column, with samples taken before and after photo-irradiation for comparison. The 
photoproduct and the reference molecules dC, PhAll-dC and dU were analyzed by FT-IR. The 
molecular weight of the new product was determined using APCI mass spectrometry. Both 1H-
NMR and 13C-NMR were used to determine the molecular structure of the new photoproduct.  
 
Photoproduct of 5-Cinnamyloxymethyl-Deoxycytidine  
1H-NMR (300MHz, DMSO-d6) δ 10.69 (s, 1H), 7.40 – 7.19 (m, 5H), 5.78 (dd, J = 9.7, 5.2 Hz, 
1H), 4.93 (d, J = 4.0 Hz, 1H), 4.77 (t, J = 5.5 Hz, 1H), 4.33 (d, J = 8.4 Hz, 1H), 4.16 (d, J = 9.1 
Hz, 1H), 4.03 (d, J = 8.9 Hz, 2H), 3.75 (d, J = 9.1 Hz, 1H), 3.64 (dd, J = 9.5, 5.6 Hz, 1H), 3.52 (d, 
J = 5.1 Hz, 1H), 3.43 (dq, J = 10.3, 4.9 Hz, 3H), 3.16 (t, J = 5.7 Hz, 1H), 1.64-1.54 (m, 1H), 0.97-
0.91 (m, 1H); 13C-NMR (300MHz, DMSO-d6) δ 171.10, 153.04, 139.44, 129.68, 129.10, 127.84, 
86.13, 83.33, 75.46, 74.24, 71.51, 62.83, 53.23, 51.62, 51.28, 50.04, 37.10; APCI-MS found: 




The novel method we are developing for genome-wide DNA methylation profiling requires site-
specific conversion of unmethylated CpG cytosines in a way that will overcome the harsh 
chemistry of bisulfite genomic sequencing. For this purpose, a model deoxycytidine molecule 
containing the photoreactive cinnamyl group at the 5 position was synthesized. The photosensitizer 
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thioxanthone (TX) was added and photo-irradiated at 350 nm to catalyze photo-conversion of 
PhAll-dC. Analysis of the main photoproduct by IR, MS and NMR proved it to be a cyclobutyl 
derivative of dT. This study shows that with our model photoactive groups and photo-irradiation 
conditions in conjunction with TX triplet sensitization, complete conversion of C to T is feasible 
























Chapter 3. DNA Methyltransferase Aided CpG Site Modification 
3.1. Abstract 
DNA (cytosine-5) methyltransferases transfer the methyl group from AdoMet onto the 5 position 
of cytosines in DNA. In this chapter, we tested the ability of prokaryotic DNA methyltransferases 
M.HhaI and M.SssI to transfer the allyl group from AdoMet analogs onto unmethylated CpG sites 
in synthetic DNA. The transfers with both enzymes took place in a site-specific manner. To 
increase transfer efficiency, M.SssI was engineered at its cofactor binding pocket to better 
accommodate larger methyl replacing groups. Three mutants of M.SssI (QA, QS, and SS) 
successfully transferred the allyl group from AdoMet analogs while retaining their natural 
methylation activity.  
 
3.2. Introduction 
The DNA methylation profiling method we are developing is a combined enzymatic-
photochemical approach suited to any current DNA sequencing platform. This novel approach is 
based on DNA methyltransferase aided site-specific conversion of unmethylated CpG 
dinucleotides. S-adenosyl-L-methionine (AdoMet) analogs derivatized with C-reactive 
functionalities will be used as substrates for DNA methyltransferases to transfer the reactive 
functionalities to the 5 position of C in unmethylated CpG islands. As demonstrated in the previous 
chapter, these covalently attached reactive functionalities initiate photoinduced intramolecular 
reactions that convert Cs to T analogs. After conversion, PCR amplification and ultrahigh 
throughput DNA sequencing will unambiguously identify all unmethylated CpG sites. 
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This chapter will focus on the enzymatic transfer of photoreactive functionalities onto 
unmethylated CpG Cs by DNA methyltransferases. Three different classes of DNA 
methyltransferases with different catalytic activities are found in nature. These are m6A DNA 
methyltransferases, m4C DNA methyltransferases and m5C DNA methyltransferases. The first 
two classes are only found in prokaryotes and methylate the amino group at the 6 position of 
adenines and the 4 position of cytosines respectively. The third class, m5C DNA 
methyltransferases, methylate the 5 position carbon of cytosine and can be found in both 
prokaryotes and eukaryotes.42 
Our work focuses on the third class of DNA methyltransferases that transfer the methyl group of 
AdoMet to the 5 position of C in unmethylated CpG sites.  Important consideration is needed to 
select an ideal m5C DNA methyltransferase or to modify it so that it will most efficiently catalyze 
the enzymatic transfer of our photoreactive group. 
 
3.2.1. AdoMet and the Synthetic Derivatives 
S-adenosyl-L-methionine (AdoMet) (Fig. 29) is the major methyl donor in methylation reactions 
catalyzed by various DNA methyltransferases. These reactions may target DNA, RNA, proteins, 
polysaccharides, lipids and other small biomolecules.43 In nature the compound is formed by L-






Besides being a methyl donor, AdoMet can also act as a cofactor for transfer reactions with larger 
methyl replacements. Previous studies by Dalhoff et al. (2006) showed that DNA 
methyltransferases can efficiently transfer larger methyl replacing groups containing unsaturated 
carbon-carbon bonds from chemically synthesized analogs of AdoMet (Fig. 30).31,32 Specifically, 
Dalhoff et al. synthesized synthetic variants of AdoMet with a variety of functional groups 
replacing the methyl group, which also permitted efficient functioning of DNA 
methyltransferases.31 Then they successfully transferred these functional groups to the 5 position 
of Cs in CpG sites using DNA methyltransferases.32 The transfer reactions produced the byproduct 
S-adenosyl-L-homocysteine (AdoHcy) given on the right side in Figure 30. 
AdoMet synthetase (methionine adenosyltransferase) forms AdoMet from ATP and L-methionine. 
Studies show that while enzymatic synthesis of AdoMet analogs in which ethyl or propyl groups 
replacing the methyl group are possible, larger replacements cannot be accomplished by AdoMet 
synthetases.32 Thus, a chemical synthesis scheme was introduced to synthesize larger analogs of 





Fig. 29 Chemical Structure of S-Adenosyl-L-Methionine.  
AdoMet is a biological compound carrying a methyl group 
attached to its sulfonium center. The compound is the major 





The synthesis of the allyl-containing AdoMet analog produces a 1:1 diastereomeric mixture at the 
sulfonium center. Since only the S-diastereoisomer of the synthesized mixture can function as the 
cofactor for the enzymatic transfer reactions, it is essential to add separation and purification steps 




Fig. 30 Scheme for Enzymatic Transfer Reactions with Cofactor AdoMet.32 In a DNA 
methyltransferase catalyzed reaction, AdoMet (R= CH3) or an AdoMet analog (R= unsaturated C-C bond 
containing side chain) acts as the cofactor where the R group is transferred onto the sequence specific 
nucleophiles in DNA. The reaction yields the modified DNA segment and an AdoHcy molecule. 
 




3.2.2. Bacterial m5C DNA Methyltransferases 
To study enzymatic transfer at the CpG level, two bacterial m5C DNA methyltransferases, M.HhaI 
and M.SssI, were chosen. 
 
3.2.2.1. M.HhaI 
M.HhaI is a m5C DNA methyltransferase that recognizes and methylates the inner cytosine in the 
sequence 5’-GCGC-3’ in double stranded DNA. The enzyme is a part of the bacterium 
Haemophilus haemolyticus’s restriction-modification system.42 Previous studies showed that 
M.HhaI is able to efficiently transfer extended side-chains from AdoMet analogs without losing 
the enzyme’s site-specificity (Fig. 32).32 
 
3.2.2.2. M.SssI 
M.SssI is a m5C DNA methyltransferase that recognizes and methylates the cytosine in all 5’-CG-
3’ (CpG) sequences in double stranded DNA using AdoMet as the donor. The enzyme is naturally 
found in the bacterium Spiroplasma monobiae strain MQ1 and has the same specificity as 
mammalian DNA methyltransferases. M.SssI may be used to drive chemical conversion of Cs to 
Ts in unmethylated CpG dinucleotides due to the enzyme's strict CpG site recognition and high 







3.2.3. Site-directed Mutagenesis of M.SssI 
The m5C DNA methyltransferases are highly conserved in sequence and structure from 
prokaryotes to mammals.11,46 Weinhold, Klimasauskas and colleagues were the first to show that 
m5C DNA methyltransferases could transfer extended groups from AdoMet analogs to CpG 
dinucleotides in double stranded DNA.45 A factor that affects the efficiency of these DNA 
methyltransferases is the steric limitations on their AdoMet binding sites in the enzyme’s catalytic 
domain.47 Engineering of these sites is a potential way to increase efficiency of transfer of the 
photoactive groups from AdoMet analogs. Kriukiené et al.48 have shown that the transfer 
efficiency of M.SssI can be increased by the substitution of bulky amino acids in the AdoMet 
 
Fig. 32 Enzymatic Transfer of Extended Side Chains by M.HhaI. Previously, it was shown that 
M.HhaI is able to transfer reactive groups other than the methyl group to the 5 position of cytosines. 
Left: Naturally occuring DNA methylation catalyzed by a DNA MTase. AdoMet is the methyl donor and 
the methyl group (red) is attached to the sulfonium ion. DNA MTase transfers the methyl group to the 
cytosine residues in CpG sites. Right: An AdoMet analog with a larger reactive group replacing methyl 
was synthesized and M.HhaI was used to successfully transfer this group to the 5 position of cytosines.45 
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binding site with amino acids that have compact side chains; they replaced both Gln142 and 
Asn370 with Ala (Fig. 33) and reported a 100-fold increase in the rate of transfer of activated 
groups. 
 
However, while the mutations reduce the enzyme’s selectivity in favor of transfer of larger groups, 
a decrease in enzymatic activity is incurred due to the increased hydrophobicity and the substantial 
reduction in the size of the amino acid side chains in the AdoMet binding site. Our collaborators 
in the Bestor laboratory, performed a similar mutagenesis on M.SssI, and also generated mutants 
with Glutamine 142 (Q142) and Asparagine 370 (N370) substituted with serine.34  
 
Fig. 33 Location of N370 and Q142 Residues in M.SssI. The bulky side chains of these amino acids 
severely constrain the size of the functional groups that can be accommodated in the cofactor binding 
site. A 100-fold increase in efficiency in the transfer of active groups from AdoMet analogs to DNA was 
reported when these amino acids were mutated to Ala by Kriukiené et al.48 
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Applying the knowledge derived from these research studies on AdoMet and enzymatic transfer 
using DNA methyltransferases, we have devised a novel method for DNA methyltransferase aided 
CpG site modification for single cell, whole genome methylome analysis. 
 
3.3. Results and Discussion 
3.3.1. Enzymatic Transfer of Allyl Group by M.SssI and M.HhaI 
To test the enzymatic transfer of reactive groups from AdoMet analogs onto unmethylated CpG 
cytosines in synthetic DNA, the following experimental scheme was designed (Fig. 34). The 
reactions aimed to utilize the difference in molecular weight of the modified and starting DNA 
segments to identify the transferred chemical group. 
To test the enzymatic transfer efficiency of the allyl group, first a control experiment was 
conducted using DNA methyltransferase M.HhaI. For this experiment, methylation was tested on 
synthetic, complementary oligonucleotides 1 and 2 given in Fig. 34. Oligonucleotide 1 has the 
sequence 5’-AGA CTT ACT AGC GCA GTG GAT CAA-3’ and has a molecular weight of 7385.9 
g/mol. Oligonucleotide 2 has the sequence 5’-TGA TCC ACT GCG CTA GTA AGT-3’ and has 
a molecular weight of 6421.2 g/mol. Both oligonucleotides contain a single 5’-GCGC-3’ sequence 
which is the recognition site for M.HhaI. The reaction products were analyzed using MALDI TOF 
MS. Upon methylation, a mass increase of 14, corresponding to the addition of the methyl group, 






The post-reaction MS spectra showed that both oligonucleotides had an exact increase of 14 in 
their molecular weights proving they were efficiently methylated using the methyl donor AdoMet 




Fig. 34 Enzymatic Transfer Reaction Scheme. Enzymatic transfer of functional groups to CpG sites 
in DNA was tested using two complementary synthethic oligonucleotides of known molecular weight. 
Both contained a CpG site. AdoMet, an allyl-containing AdoMet analog and the DNA MTases M.HhaI 





Following the methylation reaction, the allyl group was tested for transfer from the allyl-containing 
AdoMet analog (Fig. 36) using DNA methyltransferases M.HhaI and M.SssI. 
 
 
Fig. 35 MALDI TOF MS Spectra for Methylation Reaction. The top spectrum shows the molecular 
weights of oligonucleotides given in Fig. 34. Upon methylation a mass increase of 14 was expected for 
both oligos due to the addition of the methyl group. The bottom spectrum was obtained after a 
methylation reaction and shows that methylation took place successfully using M.HhaI. 
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Two reactions using M.HhaI and M.SssI were conducted to assess the effects of different 
specificities of these enzymes on transfer efficiencies of the allyl group. The allyl group has a 
molecular weight of 41 and the successful transfer of this group onto a CpG cytosine was expected 
to increase the final molecular weights of both oligonucleotides by 40. The MALDI TOF MS 
spectra obtained following the reactions showed that both oligonucleotide 1 and oligonucleotide 2 
had partial transfer of the allyl group via M.HhaI and M.SssI (Fig. 37). The top spectrum shows 
transfer results using M.HhaI. Although the expected peaks showed up for both oligos, it is seen 
that most of the starting material remained unmodified. The bottom spectrum shows the transfer 
peaks after the reaction with M.SssI and displays similar transfer efficiencies as M.HhaI. These 
results indicate that although M.HhaI and M.SssI are able to transfer methyl replacing groups from 
AdoMet analogs onto CpG sites, the efficiency of these transfers need to be improved to develop 






 Fig. 36 Allyl-Containing AdoMet Analog. The allyl-containing 
AdoMet analog contains the allyl group (red) attached to the 
sulfonium center where normally the methyl group is located. The 
analog is used as the allyl donor in the reactions catalyzed by M.HhaI 




3.3.2. Enzymatic Transfer using Mutant M.SssI* 
M.SssI has been engineered to increase the transfer efficiency of reactive groups from synthetic 
AdoMet analogs. Q142 and N370 are both located in the active site of M.SssI and mutations of 
                                                          
* Mutant M.SssI’s were constructed by Tarun Sudhir Nambiar and Caroline F. Plott from The Bestor Laboratory.  
 
Fig. 37 MALDI TOF MS Spectra for Enzymatic Transfer Reactions. The top spectrum shows the 
transfer results using M.HhaI. Peaks at 7426 and 6461 indicate that the allyl group was transferred onto 
oligo 1 and oligo 2 respectively. The bottom spectrum shows reaction results with M.SssI where again 
the peaks at 6461 and 7426 indicate partial transfer. 
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these residues to non-polar alanines is thought to open up the active site, thereby facilitating more 
efficient binding to substrates larger than a methyl group.  
When the equivalent asparagine (N304) and glutamine (Q82) residues in M.HhaI were mutated to 
alanines by Lukinavicius et al. (2012),47 this resulted in enhanced transalkylation rates with 
AdoMet analogs containing extended side chains. These investigators analyzed the effects of these 
mutations using binding and kinetic studies. DNA protection assays of N304A, Q82A and 
N304A/Q82A mutants with an AdoMet analog containing a butynyl side chain demonstrated 
catalytic turnover rates of 4.267, 0.67 and 8.533 min-1 respectively in comparison to 0.017 min-1 
for the wild type enzyme. These mutations were shown not to affect the specificity of the enzyme 
for cytosine modification. The binding affinity of AdoMet analogs to the pre-catalytic M.HhaI – 
DNA – AdoMet complex was not enhanced significantly, revealing that the improved function of 
the mutant enzymes with these AdoMet cofactors was due to catalytic transfer rather than cofactor 
binding. The mechanism for this improvement is explained by formation of a wider solvent 
channel in mutant M.HhaI’s. This modification would allow the rotation of the butynyl side chain 
to a more favorable pre-catalytic position where the two hydrogens of the transferrable carbon 
atom of the AdoMet analog would be better positioned for the nucleophilic attack of C5. Given 
the high structural and mechanistic conservation among M.HhaI and M.SssI, mutations conducted 
on M.SssI produced similar improvements in transfer of extended side chains.47,48  
We have investigated the efficiency of M.SssI upon substitution of Q142 and N370 to alanine and 
serine. It was hypothesized that the serine mutant will be more stable than the alanine variant in 
the presence of DNA and AdoMet by restoring the hydrophilic nature and relaxed specificity of 
the AdoMet binding site while maintaining the improved transfer rate of the alanine mutants.34 We 
designed M.SssI QS (Glu/Ser), QA (Glu/Ala), SA (Ser/Ala) and AS (Ala/Ser) variants to further 
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explore the effect of different combinations of substitutions at these two sites on the transfer 
activity of the enzyme. 
A HpaII restriction protection assay was used to test mutant M.SssI activity. HpaII is a restriction 
enzyme that cleaves DNA after the first cytosine in the sequence 5’-CCGG-3’ in double stranded 
DNA. The restriction by HpaII would be blocked when the inner cytosine of the sequence is either 
methylated or modified with another group. Thus, the mutant plasmid isolated from the bacteria, 
which contains multiple 5’-CCGG-3’ sites, would be resistant to HpaII digestion if it was 
expressing a functional methyltransferase. The expression plasmid in this bacteria was used to 
transcribe and translate the mutant M.SssI. However, we can also take advantage of that plasmid 
to determine whether the mutant enzyme is active in transferring methyl groups to cytosines. The 
plasmids from the mutants were isolated and digested with HpaII at 37oC for 1 h and the results 
are shown in Fig. 38. Results showed that while wild type M.SssI was completely resistant to Hpall 
digestion as expected, SS and AS mutants showed partial resistance, and the SA mutant was 
completely digested. These results confirmed that SS and AS mutants are capable of methyl 
transfer, however at an expectedly lower efficiency than the wild type due to their larger active 
site. 
This second set of M.SssI mutants (QA, QS, SS) were tested for their transfer efficiencies using 
AdoMet and the allyl-containing AdoMet analog (allyl analog) with the HpaII restriction site 
assay. 400bp DNA was treated with WT and mutant M.SssI’s in the presence of either AdoMet or 
the allyl-containing AdoMet analog up to 3 h. The optimum results were observed with 1.5 hours 
of treatment with enzymes and was followed by phenofol-chloroform extraction, ethanol 




As seen in Fig. 39, after 1.5 h incubation, QA and QS mutants showed partial enzyme activity with 
AdoMet whereas the SS mutant have been shown to retain essentially complete enzyme activity. 
Following the reactions with AdoMet, the second set of reactions were performed using the allyl-
containing AdoMet analog. The results showed that both the wild-type enzyme and the SS mutant 
could transfer an allyl group from the AdoMet analog to a 400 bp DNA fragment bearing a single 
HpaII site. Although QA and QS mutants could only demonstrate partial transfer of the allyl group, 
the SS mutant showed promising transfer efficiencies indicating that with further optimization of 




Fig. 38 Gel Picture of Wild Type and 
Mutant pCal7 Digested with HpaII for 1 
Hour. Digestion of wild type plasmid with 
methylation insensitive MspI serves as a 
positive control for digestion. The gel result 
with the isolated plasmid digested with HpaII 
indicated that the wild type was completely 
resistant to HpaII digestion as expected, SS 
and AS mutant plasmids were partially 
resistant to HpaII digestion, whereas the SA 











Fig. 39 Mutated M.SssI Variants with Enlarged Cofactor Binding Site Retain Enzymatic Activity. 
Wild-type (QN) and mutant (SS) M.SssI in which both the Gln142 and Asn370 amino acids were 
replaced with Ser were able to transfer the methyl group from AdoMet as well as the allyl group from an 
AdoMet analog, as shown by resistance to digestion by HpaII of a 400 bp DNA fragment. Complete 
protection was observed with the wild-type enzyme, nearly complete protection with the SS mutant, but 
only partial protection with the QA and QS mutants. 
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3.4. Materials and Methods 
3.4.1. Enzymatic Transfer of Allyl Group by M.SssI and M.HhaI 
3.4.1.1. Synthesis of Allyl-Containing AdoMet Analog (5-[(S)-[(3S)-3-amino-3-
carboxypropyl]prop-2-enylsulfonio]-5-deoxyadenosine)31,* 
The synthesis of AdoMet analogs carrying the allyl group was undertaken by alkylation of AdoHcy 
under mildly acidic conditions (Fig. 40). For this reaction commercially available AdoHcy was 
reacted with commercially available 3-bromo-1-propene.  
 
S-adenosyl-L-homocysteine was dissolved (20 mg, 52 mmol) in a 1:1 mixture of formic acid and 
acetic acid (3 ml) and the solution was cooled to 0oC in an ice bath. Bromo-1-propene (264 ml, 
3.12 mmol) was added to the stirred reaction solution. The solution was removed from the ice bath 
and warmed to room temperature with continuous stirring. The reaction was kept on ice for 4 days 
and its progress was analyzed by RP-HPLC (Waters). After 4 days the reaction was quenched by 
adding the reaction mixture to water (30 ml) in a separatory funnel. The aqueous phase was 
extracted with diethyl ether (3 x 5 ml) and saved. Then the aqueous phase was concentrated to 5ml 
                                                          
* Allyl-containing AdoMet analog was synthesized by Dr. Xiaoxu Li.  
 
Fig. 40 Synthesis Scheme for Allyl-Containing AdoMet Analog.31 
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using a rotary evaporator. Further purification of the sulfonium epimer of the allyl-containing 
AdoMet analog was performed by semi-preparative RP-HPLC (Supelcosil LC-18, 3 µm, 15 × 4.6 
mm, Supelco). Title product was eluted with aqueous trifluoroacetic acid (0.1%) for 2 min, then 
with acetonitrile (linear gradients to 10% in 10 min and then to 70% in 20 min) in aqueous 
trifluoroacetic acid (0.1%) with a flow of 1 mL/min. 
The isomers were detected at 254 nm. The biologically active (S)-diastereoisomer eluted with a 
retention time of 7 min and the biologically inactive (R)-diastereoisomer with a retention time of 
8 min. The solvent of the reversed-phase system was removed by lyophilization. 
The isolated (S)-diastereoisomer was characterized using ESI MS. The measured mass of the 
synthesized molecule matches the calculated molecular weight (425 Da measured, 424 Da cal.) 
(Fig. 41). 
 
 Fig. 41 ESI MS Result for (S)-Diastereoisomer of Allyl-Containing AdoMet Analog. 
65 
 
3.4.1.2. Preparation of Reaction Mixtures 
The complementary synthetic oligonucleotides were ordered from IDT. Oligonucleotide 1 had the 
sequence 5’-AGA CTT ACT AGC GCA GTG GAT CAA-3’ and had a molecular weight of 7385.9 
g/mol. Oligonucleotide 2 had the sequence 5’-TGA TCC ACT GCG CTA GTA AGT-3’ and had 
a molecular weight of 6421.2 g/mol. Both oligonucleotides were diluted to 5mM with water. Tris 
buffer (pH=7.5) was prepared by mixing 100mM Tris solution with 50 mM of 5 M HCl. 480 µl of 
Tris buffer was mixed with 10 µl of the 5 mM oligo solutions and the final solution was incubated 
at 95oC for 5 min and then cooled to allow the complementary strands to anneal.  
Three reaction mixtures were prepared to test enzymatic transfer using M.HhaI (NEB) and 
AdoMet (NEB) (reaction 1), M.HhaI and allyl-containing AdoMet analog (reaction 2), and M.SssI 
(NEB) and allyl-containing AdoMet analog (reaction 3). Reaction 1 was prepared with 2 µl 
AdoMet (16 mM), 2 µl DNA solution (100 µM), 1 µl M.HhaI (25000 U/ml), 2 µl HhaI buffer 
(10x) and 13 µl H2O. Reaction 2 was prepared with 2 µl allyl-containing AdoMet analog (16 mM), 
2 µl DNA solution (100 µM), 1 µl M.HhaI (25000 U/ml), 2 µl HhaI buffer (10x) and 13 µl H2O. 
Reaction 3 was prepared with 2 µl allyl-containing AdoMet analog (16 mM), 2 µl DNA solution 
(100 µM), 1 µl M.SssI (4000 U/ml), 2 µl NEBuffer 2 (10x) and 13 µl H2O. The reaction mixtures 
were prepared in a PCR plate and gently mixed and spun to remove any bubbles. The mixtures 
were incubated at 37oC for 2 hours. 
 
3.4.1.3. Analysis 
Following incubation, the reaction mixtures were subjected to 2 steps of purification. First PD 
MiniTrap G-10 column separation was used to clean up the samples where TEAA was used as the 
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equilibration buffer. After MiniTrap purification, the samples were ZipTip purified to prepare 
them for MALDI TOF MS (AB Voyager-DE PRO).   
First a sample of control DNA solution (oligonucleotide 1, oligonucleotide 2 and water) was 
measured by MALDI TOF MS to clearly see the peaks of both oligonucleotides without any 
modification. Then the purified reaction samples were analyzed by MALDI TOF MS to obtain the 
final molecular weights of the modified oligonucleotides. The difference in molecular weights of 
the modified and unmodified oligonucleotides was identical to the size of the modification: the 
molecular weight of the methyl group for reaction 1 and the molecular weight of the allyl group 
for reactions 2 and 3.  
 
3.4.2. Enzymatic Transfer Using Mutant M.SssI 
Engineering of M.SssI and the HpaII restriction assays were conducted by our collaborators in the 
Bestor laboratory. The detailed procedure of site-directed mutagenesis of M.SssI and the 
experimental procedures for the HpaII assays can be found in Bestor et al. (2016).34 
 
3.5. Future Directions 
To develop this novel DNA methylation profiling method fully, future efforts will focus on a 
number of steps. The first one will be the direct attachment of the photosensitizer, TX, to the 
photoactive group to test photo-conversion. Covalently attaching TX to the cinnamyl chromophore 
rather than providing it free in the reaction mixture would increase photo-conversion efficiency 
and reduce the likelihood of any unexpected side reactions.  If the sensitizer (TX) is covalently 
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linked to the cinnamyl group, intramolecular triplet energy transfer will deactivate the TX triplet 
state within a few nanoseconds to generate triplet excited states of the cinnamyl group, which then 
react with the double bond of dC via [2+2] photocycloaddition.  Because of the orders of 
magnitude reduced TX triplet lifetime from microseconds to nanoseconds (due to intramolecular 
triplet energy transfer) undesired side reactions, such as electron transfer reactions are highly 
unlikely. Fig. 42 shows the molecular structure of a model compound which has photosensitizer 
(TX) covalently attached for testing the intramolecular sensitization concept. 
 
Synthesis and testing of TX-conjugated model compounds will be followed by the synthesis of 
photosensitizer-containing AdoMet analogs. These analogs will deliver a highly efficient 
photoactive group to the unmethylated CpG Cs in double stranded DNA. Fig. 43 shows the 









 Since we study DNA methylation patterns in the CpG context, a way to make our method highly 
cost efficient would be by limiting our analysis to DNA segments that contain CpG sites. CpG 
sites are underrepresented in the human genome with only about 20% of all DNA sequences 
containing a CpG dinucleotide.  Thus, to prevent extra sequencing costs, an azido or as shown in 
Fig. 44, an alkyne moiety will be added to the AdoMet analog. Consequently, only DNA 
segments that contain unmethylated CpGs will be captured by click chemistry and purified using 
alkyne or azido magnetic beads respectively.49 
 
Fig. 43 Molecular Structure of a TX-Containing AdoMet Analog. 
 




Besides these efforts, we will also continue to mutate M.SssI for better transfer efficiency with 
AdoMet analogs. Therefore, the overall workflow of this new genome-wide DNA methylation 
profiling method will consist of enzymatic transfer of a C-reactive moiety to the 5 position of C as 
illustrated in this chapter, photoreactions leading to C to T analog conversion as described in 
Chapter 2, sequencing sample preparation and lastly integrated high-throughput DNA sequencing 
and data interpretation. The final scheme is given in Fig. 45.  
 
 
Fig. 45 Summary of The Overall Scheme of DNA Methylation. For whole genome methylation 
profiling of cell lines, all unmethylated CpG dinucleotides will be modified with photoreactive groups 
carried by AdoMet analogs and transferred using optimized M.SssI. The DNA will be photo-irradiated 
with 350 nm light to induce photo-conversion. At the last step, the converted samples will be analyzed 
by next-generation sequencing to identify all sites that were unmethylated in the starting DNA by their 
conversion from CpG to TpG.  
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This new method carries the potential to be used at the single cell level for methylome analysis of 
DNA. Whole-genome sequencing from single cells is recognized as the essential next step in 
genome biology and anticipated to be useful in many clinical applications. 
 
3.6. Conclusions 
The ability of DNA methyltransferases to transfer groups other than methyl onto CpG sites is 
essential for our method. To validate this process we have tested the transfer of the allyl group 
using m5C DNA methyltransferases M.SssI and M.HhaI. The results of these transfers proved to 
be positive, however were not efficient enough. To increase transfer efficiency of M.SssI, 
mutations were installed in its cofactor binding pocket to accommodate larger side chains. Three 
mutants prepared for this purpose were able to transfer an allyl group from AdoMet analogs while 
also retaining their natural methylation activity. These experiments indicated that with optimized 
engineering of DNA methyltransferases, larger functional groups replacing the methyl group can 
be transferred to DNA with very high transfer efficiency and site-specificity. Following this step, 











Chapter 4. Introduction to Walking Approach for DNA Sequencing by Synthesis 
4.1. The Human Genome Project 
Completed in 2003, The Human Genome Project (HGP) made history by mapping the complete 
human genome for the first time. Sequencing the genome during the project was based on a 
technique called shotgun sequencing. Human DNA was fragmented into ⁓200,000 bp long 
segments, which were amplified via Bacterial Artificial Chromosome (BAC) clones and stored as 
BAC libraries.50 These libraries of human DNA fragments were sequenced using Sanger shotgun 
sequencing. The overall project including initial years focused on low resolution mapping and 
disease gene discovery was completed in 13 years and cost $2.7 billion. 51 
 
4.1.1. Sanger Sequencing 
4.1.1.1 Catalytic Mechanism of DNA Polymerase during DNA Synthesis 
Sanger sequencing is a first-generation DNA sequencing technology based on selective 
incorporation of dideoxynucleotides (ddNTPs) by DNA polymerase during elongation of a DNA 
strand complementary to the template strand. During natural DNA synthesis, DNA polymerase 
uses one strand of the DNA as the template, slides through the template in the 3’ to 5’ direction, 
and replicates it in the 5’ to 3’ direction (Fig. 46).  Replication takes place as DNA polymerase 
positions the 3’-OH group of the growing strand towards the incoming nucleotide. Two metal ions, 
Mg2+ or Mn2+, assist in catalysis. Once the hydrogen bonds between the new base pair are formed, 
the polymerase stimulates the pyrophosphate group to leave, forming a new covalent 
phosphodiester bond between the growing strand and the incoming nucleotide. DNA polymerase  
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then proceeds to attach the next nucleotide. 
 
Fig. 46 Catalytic Mechanism of DNA Polymerase. Two metal ions, Mg2+ or Mn2+, assist in 
incorporation of the incoming nucleotide (red). One reduces the affinity of the hydrogen in the 3’-OH 
group (blue) to facilitate an attack by oxygen on the alpha phosphate of the incoming nucleotide. The 
second metal ion facilitates the pyrophosphate group to leave. 
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During Sanger Sequencing, ddNTPs are used to terminate strand elongation as these nucleotides 
lack the 3’-OH group required to form the phosphodiester bond with the subsequent incoming 
nucleotide (Fig. 47).52 In this sequencing method, 4 separate reaction mixtures are prepared. In 
each mixture, the single stranded DNA segment to be sequenced is placed together with DNA 
polymerase, primer and four deoxynucleotides (dNTPs). The ddNTPs are added to the reaction at 
about two orders of magnitude lower concentrations than dNTPs. Extension reactions are run for 
multiple rounds. Since the concentration of ddNTPs is much lower than that of dNTPs, these 
terminators are added randomly opposite complementary bases in different growing chains. 
 
Due to this random termination, different sized extended primers are obtained for each of the 
reactions. After denaturing these elongated DNA products, they are analyzed using gel 
electrophoresis and are typically visualized by the aid of fluorescent labels (Fig. 48).  
 
 
Fig. 47 Chemical Structure of dATP vs. ddATP. During strand elongation, DNA polymerase connects 
the 3’-OH group of the primer to the 5’-phosphate group of the incoming nucleotide forming a 





Although serving as the primary sequencing method for a long time, Sanger sequencing has limited 
ability to produce large amounts of sequence data due to the need for size separation using slab or 
capillary gel electrophoresis. Being able to sequence only a few genes at a time, the technology 
could not meet the demands of the scientific world as the progress in biological and medical 
research required much faster and more accurate technologies at lower cost.54 Following the HGP, 
the world of DNA sequencing has taken a turn into next generation DNA sequencing technologies 
where massively parallel platforms aim at sequencing at whole genome scale with single base 
resolution. 
 
4.2. Next Generation DNA Sequencing (NGS) 
High-throughput sequencing has revolutionized biotechnology by facilitating access to different 
types of biomedical inquiries that had been difficult to answer with first generation sequencing 
technologies.50 These inquiries were aimed at development of better diagnostics, more thorough 
 
Fig. 48 Sanger DNA Sequencing using ddNTPs.53 Extension of the primer is terminated with the 
incorporation of one of the ddNTPs rather than the corresponding dNTP. The elongated strands are then 
separated on a gel matrix showing the product sizes for each reaction.  
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understanding of disease mechanisms and development of new therapies. By producing very large 
amounts of sequence reads efficiently and rapidly, next generation DNA sequencers enabled 
identification of genomic variations, discovery of disease-associated markers and led to molecular 
evolutionary analyses in animals and plants.54 
 
4.2.1. Sequencing by Synthesis (SBS) Methods 
Sequencing by synthesis is a sequencing method that uses DNA polymerase aided extension of a 
complementary DNA strand to decipher the sequence of a template (Fig. 49). During extension, 
tagged nucleotides are used to identify the bases being incorporated. SBS is used in a number of 
next generation sequencing platforms where it is coupled with different technologies.  
 Fig. 49 Sequencing by Synthesis Workflow.55 
SBS utilizes DNA polymerase aided stepwise 
synthesis of a complementary DNA strand to 
decipher the sequence of a template. Either natural 
or labeled dNTPs can be used for synthesis 
depending on the sequencing technology used. In 
most SBS methods, labeled dNTPs are used to 
identify the incorporated nucleotide via an imaging 
step. These labels are subsequently removed to 
allow the next cycle of incorporation and imaging. 
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Several commercialized SBS approaches exist that use different readouts, e.g., Roche 454 GS FLX 
(luminescence), Illumina Solexa Genome Analyzer (fluorescence) and IonTorrent (electronic). I 
will only briefly discuss the first two methods.  
 
4.2.1.1. Roche 454 GS FLX Pyrosequencer 
The first NGS technology, the 
Roche 454, was a pyrosequencer 
detecting the pyrophosphate 
released during DNA extension. 
For this method, the DNA to be 
sequenced is first fragmented and 
amplified via emulsion PCR. 
After denaturation, the primer is 
added along with DNA 
polymerase and a single dNTP. As DNA polymerase incorporates a matching dNTP, a 
pyrophosphate molecule is released into the solution. Through a series of enzymatic reactions, the 
pyrophosphate is converted into ATP which elicits luminescence through converting luciferin into 
oxy luciferin (Fig. 50).54 The detection of luminescence confirms that the dNTP is incorporated. 
Roche 454’s pyrosequencer could produce up to 400-700 bp read length per run, but was limited 
in identifying homopolymer sequences exceeding 6 bases since pyrosequencing chemistry allows 
multiple additions of identical consecutive nucleotides in the same cycle.54 Another difficulty 
arises from the fact that each of the four dNTPs needs to be added and detected separately 
throughout the process, increasing the overall detection time.57                                          
 
                         Fig. 50 Roche 454 Workflow.56 
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4.2.1.2. Illumina Solexa Genome Analyzer 
Illumina’s Genome Analyzer uses the reversible terminator technology for whole genome 
sequencing of DNA. Reversible terminators terminate new strand synthesis upon incorporation as 
their 3’-OH group is blocked by a chemically reversible moiety. However, upon cleavage of this 
blocking group, the 3’-OH is freed and incoming nucleotides can be successfully incorporated by 
DNA polymerase.  
The reversible terminator technology was investigated by several groups including Metzker et al. 
(1994)58 and Canard et al. (1994)59. These efforts were not successful in design and synthesis of 
nucleotide analogs for polymerase incorporation. Ju et al. were the first to successfully design and 
synthesize a novel set of nucleotide reversible terminators (NRTs) for their use in a new DNA 
sequencing system.57 NRTs can also be attached to fluorescent dyes to emit light during the 
sequencing reaction. Fluorescent NRTs, invented bu Ju et al., are usually modified at two specific 
locations. The first modification is a blocking group at the 3’-OH position, with a small chemically 
reversible moiety, and the second modification is a fluorophore linked via a cleavable linker to the 
base (Fig. 51). Each base is linked to a fluorophore with a distinct emission profile; in this way the 
detected emission is used to identify the incorporated nucleotide.57   
The Ju lab has successfully designed and synthesized several sets of NRTs with different blocking 
groups for SBS (Fig. 52). I will introduce three of them in this section and will discuss a fourth 
set, containing novel disulfide linkers, in detail in Section 4.3. The first set of aforementioned 
novel fluorescent NRTs are 3’-O-allyl-dNTPs-allyl-fluorophore.57 In this set, the 3’-OH is capped 
by an allyl moiety and an allyl based linker is used to attach four distinct fluorophores to the bases 
(Fig. 52, a). Both the allyl moiety and the linker can be cleaved by Pd-catalyzed deallylation in 




3’-O-PC-dNTPs.61 In this set the 3’-OH is capped by a nitrobenzyl moiety which can be cleaved 
by 355 nm photo-irradiation, regenerating the 3’-OH for the next cycle of sequencing (Fig. 52, b). 
A third set of NRTs are 3’-O-N3-dNTPs-N3-fluorophore and their analogs.61 These NRTs are 
capped by an azidomethyl moiety at the 3’-OH and an azido based linker is used to attach four 
distinct fluorophores to the bases (Fig. 52, c). Both the azidomethyl moiety and the linker can be 
cleaved by 100 mM tris(2-carboxyethyl)phosphine (TCEP) (pH 9.0) at 65°C in less than 10 
minutes. This set of fluorescent NRTs were used in early versions of Illumina Solexa DNA 
sequencing systems. The fourth set of NRTs are 3’-O-DTM-dNTPs-SS-fluorophore (Fig. 52, d). 
These NRTs contain a dithiomethyl group blocking the 3’-OH as well as a dithiomethyl based 
linker to attach the fluorophore. Both the blocking group and the linker can be easily cleaved by 
treatment with TCEP or 5mM tris(hydroxypropyl)phosphine (THP) at 65°C for 3 minutes. 
 
Fig. 51 3’-O-blocked Reversible Terminator.60 The fluorophore is linked to the base via a cleavable 
linker which is cleaved after the fluorescent emission of the dye is detected. At the same time, the 




In the four classes of the nucleotide analogs listed above and in Fig. 52, the NRTs containing bulky 
3’-O-blocking moieties, such as 2-nitrobenzyl group, are not efficiently incorporated by DNA 
polymerase in comparison to NRTs with smaller 3’-O-blocking groups, such as the allyl group, 
due to the space limitation in the active site of the polymerase.  
 
 
Using SBS with fluorescent NRTs, Illumina’s Genome Analyzer is one of the leading platforms 
in DNA sequencing.62 For this method, first the DNA template to be sequenced is fragmented and 
amplified on the slide surface via a method called bridge PCR.63 For the sequencing by synthesis 
step, all four reversible terminators are added to the reaction mixture along with the template, 
primer and DNA polymerase. 
Once DNA polymerase adds the single matching nucleotide to the elongating strand, the 
fluorescent dye of the nucleotide is imaged, identifying the base incorporated. Following imaging, 
DNA polymerase and unused nucleotides are washed off and the fluorophore and the 3’-blocking 
group are chemically removed to prepare the strand for the next incorporation step (Fig. 53).57 
 
Fig. 52 Structures of 3’-Blocking Groups used in NRTs. An allyl group (a), a nitrobenzyl group (b), 
an azidomethyl group (c) and a dithiomethyl group (d) are used as cleavable chemical groups.  The wavy 
line represents the point of attachment to the 3'-O atom.  
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Illumina’s Genome Analyzer provides high throughput sequencing at low cost per base but is 
limited in its ability to produce long read lengths as template missteps at each cycle accumulate 








Fig. 53 Example Scheme for Sequencing by Synthesis with Fluorescent Nucleotide Reversible 
Terminators.57 (1) Addition of 3’-O-allyl-dNTPs-allyl-fluorophore and DNA polymerase, (2) Imaging 





4.3. The Sequence Walking Approach 
To overcome the read length limits of current SBS technologies, we propose a novel Sequence 
Walking strategy for DNA sequencing by synthesis, using the reversible terminator technology. 
This method aims to increase one-time sequencing length of DNA three-fold or more at 
comparable costs and accuracy. A big challenge of increasing read lengths in SBS lies in the 
decreasing number of templates that can be sequenced after each reaction cycle. The cleavage of 
the fluorescent label on the base after each detection leaves a small chemical residue, possibly 
decreasing the ability of DNA polymerase to bind to the double stranded DNA and efficiently 
incorporate the incoming nucleotide. Due to this problem, the number of templates sequenced in 
each cycle decreases.61a Another limiting factor for read lengths would be the buildup of the 
cascade of unused nucleotides following each incorporation event. Washing steps are necessary to 
remove prior sets of reagents after each step but can lead to detachment of template DNA, causing 
significant losses in signal density. 
Increasing the read length per run is possible by improving two conditions. The first would be 
designing new nucleotide reversible terminators that would leave no chemical remnants on the 
base after cleavage of the fluorescent label. Use of such reversible terminators can prevent losses 
in incorporation efficiency after each cycle and keep the number of templates that are sequenced 
relatively constant. However, the design and synthesis of these molecules requires further research 
and perhaps introduction of new techniques to regenerate bases lacking chemical remnants during 
the sequencing reaction. The second solution can be attained by reducing the overall number of 
consecutive steps that would produce reversible terminators with chemical residues on the base. 
This is possible by minimizing the total number of incorporations of nucleotide reversible 
terminators per run for sequencing a given template. To realize that, we have developed a novel 
83 
 
method that couples 4-color SBS with walking reactions. The walking reactions utilize one 
nucleotide reversible terminator together with three unmodified dNTPs. Each walking reaction or 
‘walk’ is terminated at the predesignated base using a single type of nucleotide reversible 
terminator while the remaining three dNTPs are used in new strand synthesis until the reaction is 
terminated.  
The Sequence Walking Approach ultimately involves three steps (Fig. 54). In the first step, 4-color 
SBS using fluorescent nucleotide reversible terminators is performed on the template for a given 
number of bases. In the second step, the extended primer is stripped away and the original primer 
is annealed to the template. The main rationale behind this step is the removal of the sequenced 
strand and reattachment of the original primer to allow the extension of the template using a mix 
of natural and modified nucleotides.61a In the third and final step, a walk is performed using three 
dNTPs and one nucleotide reversible terminator to reach approximately the end point of the first 
round SBS. Since the walk is carried out using dNTPs and only a single type of NRT, the 
subsequent round of SBS can be performed on the nascent DNA strand for maximum read length. 
These three steps are repeated until a desired length of the template is sequenced. Using this 
method, the loss of signal due to out of phase templates would be avoided. With these advantages, 







The first step, 4-color SBS, is performed using fluorescent nucleotide reversible terminators (e.g. 
3’-O-tert-butyldithiomethyl-dNTPs-SS-Dye). This particular set of NRTs consists of novel 
molecules designed and synthesized in our lab.64 3’-O-tert-butyldithiomethyl-dNTPs-SS-Dye (3’-
O-DTM-dNTPs-SS-Dye) have their 3’-OH groups blocked by tert-butyldithiomethyl (DTM), so 
that they are still recognized by DNA polymerase as substrates to extend the DNA chain, but 
terminate new strand synthesis upon incorporation. DTM is easily cleavable under mild, reducing 
conditions.65 
Each fluorescent reversible terminator contains a label with a distinct fluorescent emission profile 
that is attached to the base via a cleavable disulfide linker. Sequences are determined by the unique 
fluorescence emissions of fluorophores on these molecules. The molecular structures of 3’-O-
DTM-dNTPs-SS-Dye are given in Fig. 55. 
 
Fig. 54 Overall Scheme for The Sequence Walking Approach.61a Following 4-color SBS, the extended 
primer is denatured and a copy of the initial primer is annealed. A walk is performed using three dNTPs 
and one nucleotide reversible terminator up to approximately where the original SBS ended. The cycle 




Fig. 55 The Molecular Structures of Fluorescent Nucleotide Reversible Terminators (3’-O-tert-
Butyldithiomethyl-dNTP-SS-Dye Compounds). The 3’-OH of each molecule is protected with DTM. 
A unique fluorescent dye is attached to each base via a disulfide-containing cleavable linker. The 
absorption maxima of the dyes are at 530 nm for R6G, 586 nm for ROX, 495 nm for Alexa488 and 649 
nm for Cy5.  
 
Each SBS cycle consists of extension, chase and cleavage (Fig. 56). During extension, DNA 
polymerase adds the complementary 3’-O-DTM-dNTP-SS-Dye to the 3’ end of the primer or the 
self-priming template. After a wash, 4-color imaging is used to detect the fluorescent intensity on 
the chip, to determine the incorporated base. During imaging, the DNA is excited at 488 nm, 542 
nm, 594 nm, and 633 nm in accordance with the absorption maxima of fluorescent tags contained 
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in the 3’-O-DTM-dNTPs-SS-Dye. Imaging is followed by the chasing step. The chase mixture 
consists of the four dark nucleotide reversible terminators (3’-O-DTM-dNTPs). As NRTs of this 
type have a higher polymerase incorporation efficiency due to their lack of the bulky dyes, chasing 
is used as a step to extend any remaining 3’-OH that was not extended by a 3’-O-DTM-dNTP-SS-
Dye during the extension step. 
Treatment with tris(hydroxypropyl)phosphine (THP) cleaves both the fluorophore and the 3’-
DTM group, regenerating the 3’-OH of the extended template (Fig. 57). Lastly, washing and 




Fig. 56 Overall Scheme for 4-color SBS using 
Fluorescent Nucleotide Reversible 
Terminators. Incorporation of 3’-O-DTM-
dATP-7-SS-ROX during SBS using an 
immobilized self-priming template is shown as 
an example. From the mixture of 3’-O-DTM-
dNTPs-SS-Dye, 3’-O-DTM-dATP-7-SS-ROX 
is incorporated into the growing strand by DNA 
polymerase. After washing and imaging, THP 
treatment is used to cleave the fluorescent dye 
and the 3’-O-DTM group, preparing the template 





After the first round (e.g., 30 cycles) of 4-color SBS, the elongated primer is removed from the 
template by denaturation. The original primer is annealed to the template to prepare for the walking
 
 
Fig. 57 Cleavage Scheme of DTM Blocking Group and Cleavable Linker during THP Treatment. 
Both the DTM blocking group and DTM linker can be cleaved in a single step with an aqueous solution 
of THP (green). Cleavage results in a leaving thiol group and a SH residue on both tails attached to the 
base and to the 3’-OH which then intrinsically self-collapse into a stable OH group.  
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reactions. Unlike 4-color SBS, walking reactions utilize three dNTPs and one of the 3’-O-DTM-
dNTPs. These NRTs (the same ones used for chase reactions) have their 3’-OH groups blocked by 
DTM, but do not contain fluorescent dyes.  The structures of these molecules are given in Fig. 58. 
 
During a walk, three dNTPs are used to elongate the primer during the polymerase reaction. The 
reaction stops when the incoming 3’-O-DTM-dNTP that is complementary to the sequence is 
incorporated into the growing strand by DNA polymerase. Upon incorporation, the DTM group 
 Fig. 58 Molecular Structures of 3’-O-DTM-dNTPs. This set of reversible terminators are used during 
walking reactions as well as chase reactions. In 3’-O-DTM-dNTPs, the 3’-OH group is blocked by DTM 
which prevents further elongation by DNA polymerase and can be easily removed upon treatment with 
a disulfide reducing agent. 
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prevents further synthesis by blocking the 3’-OH of the elongated strand and terminates the walk. 
Treatment with THP removes the blocking moiety from the extending primer, regenerating the 3’-
OH for further elongation (Fig. 59). Walking reactions and 4-color SBS follow each other in 





Following the completion of The Human Genome Project, next generation sequencing platforms 
were developed with the aim of increasing throughput, accuracy and economics of DNA 
sequencing. Fluorescence-based next generation SBS methods generated major improvements 
over the first generation technologies, but are limited by their read lengths. In this regard, we have 
developed an SBS method called The Sequence Walking Approach to overcome current 
challenges in increasing the one time read length of DNA. The Sequence Walking Approach 
 
Fig. 59 Incorporation and Cleavage of 3’-O-DTM-dNTP During a Walk. 
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utilizes natural dNTPs together with NRTs in reactions called ‘walks’ that terminate at 
predetermined bases instead of after each incorporation. By reducing the accumulation of cleavage 
artifacts of NRTs in a single run, our method aims to reach longer read lengths with low costs and 
high accuracy. In the following chapter, I will describe a variation of The Sequence Walking 
Approach, as proof of principle, in which 4-color sequencing steps are interspersed with walking 























Chapter 5. Walking Approach for Increasing Read Length of DNA Sequencing by Synthesis 
5.1. Abstract 
Fluorescence-based next generation SBS technologies provide high throughput and high accuracy 
DNA sequencing, but are limited in their ability to sequence long portions of the genome in a 
single run. Here, we have tested the proof of principle for a new method, The Sequence Walking 
Approach, to improve sequencing read lengths of current fluorescent SBS technologies using 
dNTPs and nucleotide reversible terminators. The experiments performed in solution and on chip 
showed that our method is capable of extending current read lengths up to several fold while 




Our Sequence Walking approach to achieve longer read lengths is based on repeated cycles of 4-
color SBS followed by walking reactions until the given template is entirely sequenced. The 
ultimate version of the method relies on replacing the elongated primer with the original primer 
for the walking reactions following 4-color SBS. The Sequence Walking Approach ensures that 
the template is sequenced in its entirety including the ‘walked’ sequences. To test the viability of 
our method, we have adopted a simpler approach by continuously repeating 4-color SBS and 
walking reactions on the original primer.  
Each walking reaction will utilize three dNTPs and a fourth nucleotide reversible terminator as 
substrates. The elongation of the primer will only be stopped once the NRT is incorporated. After 
incorporation, THP treatment will be applied to regenerate the 3'-OH on the incorporated NRT to 
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ensure consecutive incorporation in the next round. Repeated cycles of walking reactions and 
cleavage will fill the gap between the first and second stages of 4-color SBS (Fig. 60). 
 
Once the walks are completed, a second round of 4-color SBS will be conducted using fluorescent 
nucleotide reversible terminators. The 4-color SBS – walking – 4-color SBS process will be 
repeated to generate maximum read length. Even though this initial approach does not provide 







Fig. 60 Scheme for The Sequence Walking Approach. An example scheme is shown in the figure with 
two cycles of walking reactions using three natural dNTPs (dCTP/dGTP/TTP) and one 3’-modified 
dATP (reversible terminator 3’-OR-dATP) on a known template followed by 4-color SBS. 
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5.3. Results and Discussion 
5.3.1. Walking Approach in Solution using 3’-O-tert-Butyldithiomethyl-dGTP 
The first set of walking experiments were performed in solution phase using a single type of 
nucleotide reversible terminator, 3’-O-tert-butyldithiomethyl-dGTP (3’-O-DTM-dGTP).  The 
structure of the molecule is given in Fig. 61. 
The DNA template to be sequenced was a 49mer designated WT49G and had the sequence                             
5'-CAGCTTAAGCAATGGTACATGCCTTGACAATGTGTACATCAACATCACC-3‘. The 
primer annealing sequence is highlighted in yellow. The primer for the reaction was a 13mer with 
the sequence 5'-CACATTGTCAAGG-3‘. Each walking reaction aimed to elongate the primer 
until the incorporation of the next G (corresponding Cs on the template) where the new strand 
synthesis would be terminated due to incorporation of 3’-O-DTM-dGTP. The red marked Cs on 
the WT49G sequence indicate the end of each walk.  
The 1st walk was performed using WT49G, 13mer, 3’-O-DTM-dGTP, dATP, dCTP, dTTP and 
DNA polymerase. The result of the reaction was analyzed via MALDI TOF MS based on the 
difference in molecular weights of the elongated primer and the starting 13mer. The 13mer was 
expected to be elongated by nucleotides dCTP, dATP, dTTP and lastly by 3’-O-DTM-dGTP after 
 
 
Fig. 61 Molecular Structure of 3’-O-DTM-
dGTP This reversible terminator is blocked 
at its 3’-OH by DTM and has a molecular 




which the walk would be terminated. The expected molecular weight of the reaction product was 
calculated to be 5328. MALDI TOF MS analysis of the product showed a single peak at 5330 
which indicated that extension during the walk took place as expected (Fig. 62, left).         
 
Each walk was followed by THP treatment of the elongated primer to remove DTM from the 
incorporated reversible terminator. Only after successful de-protection of the 3’-OH can the next 
walk can take place. Removal of the blocking group is expected to reduce the molecular weight 
 
 
Fig. 62 1st Walk using 3’-O-DTM-dGTP, dATP, dCTP, dTTP and WT49G. The 1st walk was 
performed using the nucleotides dATP, dCTP, dTTP and a single reversible terminator 3’-O-DTM-
dGTP. Extension with these nucleotides was expected to yield a final product with a molecular weight 
of 5328. The MALDI TOF mass spectrum (left) showed a peak at 5330 (+/- 4 error is acceptable for the 
instrument) indicating the extension took place as expected. The walk was followed by THP treatment 
of the extension product to remove the blocking group which would yield a final product with a molecular 




by 134 g/mol. The MALDI TOF MS spectrum following THP treatment showed that the obtained 
peak matched the molecular weight of the expected product (Fig. 62, right).  
The 2nd walk was performed in a similar fashion where the 1st walk primer, 13mer, was replaced 
with the 1st walk product, a 17mer. The MALDI TOF MS spectrum obtained after the reaction 
showed that the obtained peak matched the expected molecular weight of the extension product 
(Fig. 63, left). The 2nd walk was followed by THP treatment where the observed molecular weight 
seen in the spectrum matched the expected mass (Fig. 63, right).  
 
Fig. 63 2nd Walk using 3’-O-DTM-dGTP, dATP, dCTP, dTTP and 1st Walk Product (17mer) as the 
New Primer. The 2nd walk was performed using the nucleotides dATP, dCTP, dTTP and reversible 
terminator 3’-O-DTM-dGTP. Extension with these nucleotides was expected to yield a final product with 
a molecular weight of 7775. The MALDI TOF mass spectrum (left) produced a peak at 7771 that 
signified the extension took place as expected. The walk was followed by THP treatment of the extension 
product to remove the blocking group. The MALDI TOF MS peak at 7643 (right) against the expected 
peak at 7641 indicates that blocking group removal was also successful. 
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During the 3rd walk, the 2nd walk product, a 25mer, was used as the new primer. After extension 
the peak obtained by the MALDI TOF MS showed that the 6 base long extension took place as 
expected (Fig. 64).  
 
The three walks performed on synthetic DNA showed that The Sequence Walking Approach 
worked efficiently in solution phase using a single type of reversible terminator. The walks ranged 
from 4 to 8 bases and the number of bases incorporated did not interfere with walking efficiency 
within this range. The THP treatment step after the 1st and 2nd walks successfully removed the 
blocking group of the incorporated reversible terminator, de-protecting the 3’-OH and allowing 
 
Fig. 64 3rd Walk using 3’-O-DTM-dGTP, dATP, dCTP, dTTP and 2nd Walk Product (25mer) as 
the New Primer. The 3rd walk was performed using the nucleotides dATP, dCTP, dTTP and reversible 
terminator 3’-O-DTM-dGTP. Extension with these nucleotides was expected to yield a final product with 
a molecular weight of 9628. The MALDI TOF mass spectrum showed a peak at 9625 that signified the 
extension took place as expected.  
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for the next incorporations.  Procedures for the walks and THP treatment steps were easy and fast, 
indicating the convenience of the method for future use. 
 
5.3.2. Walking Approach on Surface-Immobilized DNA using 3’-O-tert-Butyldithiomethyl-
dNTPs and 3’-O-tert-Butyldithiomethyl-dNTPs-SS-Dye 
To test the viability of our method for an actual sequencing system, the next set of experiments 
were designed to utilize longer walks using all four types of fluorescent NRTs. The walks were 
performed using solid phase reactions on a glass slide with sequencing data obtained through 
reading of laser induced fluorescence from dyes attached to reversible terminators. Self-priming 
DNA templates to be sequenced were immobilized on the glass slide. The slide contained eight 




Fig. 65 Glass Slide for Solid Phase Sequence Walking Approach. Each slide contains 8 subarrays 
with self-priming templates immobilized on the glass surface. The subarrays with the same color indicate 
a single type of template and are expected to produce identical sequencing data. 
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5.3.2.1. Nonspecific Binding Assay  
Before performing 4-color SBS, first the system was tested for nonspecific binding of fluorescent 
NRTs to the glass surface that could potentially distort reading accuracy by reducing the signal-
to-noise ratio. We have designed a single base extension (SBE) reaction to perform on the slide 
using all four fluorescent nucleotide reversible terminators. The first row of subarrays on the slide 
went through SBE reactions with the polymerase whereas for the second row of subarrays 
incubations were conducted in the absence of polymerase. After the wash and scan, the difference 
in the signal intensities of the two rows helped us determine the extent of nonspecific binding. The 
results showed that for the top row of the reaction with the polymerase, SBE reactions took place 
as expected with readings for all four templates giving accurate base signals. On the contrary, in 
the absence of the polymerase in the second row, the signal intensities of templates post-reaction 
matched background levels indicating the absence of nonspecific binding on the surface (Fig. 66). 
 
5.3.2.2. The Sequence Walking Approach  
The Sequence Walking Approach was performed on 6 subarrays containing 4 different template 
types of known sequence. On each template, 4 rounds of 4-color SBS using fluorescent NRTs and 
3 rounds of walking reactions were performed.  The lengths of the walks ranged from 1 to 6 bases 
depending on the specific sequences of different self-priming looped templates. Identical templates 
were expected to produce identical sequencing data. The longest Sequence Walking performed on 
the slide was 39 bases, close to the full length of the templates. The results are given in Fig. 67. 
As seen, all bases were called correctly during SBS cycles for each template. This also indicated 




rounds of walking and sequencing on different DNA templates with very high accuracy indicating 
our Sequence Walking method is capable of increasing continuous read lengths of fluorescence 
based SBS methods at least several-fold.   
 
Fig. 66 Nonspecific Binding Assay. The two rows of subarrays on the slide were prepared for SBE 
reactions using all four fluorescent NRTs. For the bottom row, the polymerase was left out of the reaction 
mixture. In the absence of the polymerase, only baseline signal was recorded showing that all unused 
nucleotides were successfully washed off prior to scanning. The slide did not contain the 2nd subarray in 












Fig. 67 The Sequence Walking Data using 4-Color SBS and Walking Reactions. 
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5.4. Materials and Methods 
5.4.1. Incorporation of 3’-O-DTM-dGTP in Solution 
Detailed description of the synthesis scheme and characterization for 3’-O-DTM-dGTP is given 
in Dr. Jianyi Ren’s thesis ‘Design and synthesis of novel cleavable fluorescent nucleotide 
reversible terminators using disulfide linkers for DNA sequencing by synthesis.’64 
 
Walking reactions in solution were performed using nucleotide reversible terminator 3’-O-DTM-
dGTP, natural deoxynucleotides dATP, dCTP, dTTP and walking template WT49G. WT49G is 
designed for a 4 base extension on the primer (13mer) during the 1st walk, 8 base extension during 
the 2nd walk and 6 base extension during the 3rd walk after which the reaction stops at the first 
corresponding C on the template. The lengths of WT49G and 13mer were designed for efficient 
characterization by MALDI TOF mass spectrometry using an Applied Biosystems Voyager-DE 
PRO. 
The reaction (50 µl) was carried out using 1 µmol 3’-O-DTM-dGTP, 1 µmol each dATP, dCTP 
and dTTP, 500 pmol 13mer (MW 3939), 5 units Therminator IX DNA Polymerase (NEB), 300 
pmol WT49G in a 5 µl buffer containing 20 mM Tris-HCl solution, 10 mM (NH4)2SO4, 10 mM 
KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 at 25
oC and 100 pmol MnCl2. The reactions were 
conducted in an ABI GeneAmp PCR System 9700 with initial incubation at 65oC for 30 seconds, 
followed by 38 cycles of 65oC/30 sec, 45oC/30 sec, 65oC/30 sec. The reaction mixtures were 
desalted using Oligo Clean & ConcentratorTM (ZYMO Research) and analyzed by MALDI TOF 
MS (AB Voyager-DE PRO). The cleavage reaction was carried out using THP at a final 
concentration of 5mM incubated at 65oC for 5 minutes, then the reaction mixtures were desalted 
using Oligo Clean & ConcentratorTM (ZYMO Research) and analyzed by MALDI TOF MS.  
104 
 
The products for each walk were purified and isolated using RP-HPLC (Waters) with a semi-
preparative column (Supercosil LC-18, 3 µm, 15  4.6 mm, Supelco). 1st walk product (17mer, 
M.W.5194) was used in place of the primer for the 2nd walk and 2nd walk product (25mer, 
M.W.7641) was used as the primer for the 3rd walk. The amounts of nucleotides were adjusted in 
each walk according to extension length (2 µmol in 2nd walk and 1.5 µmol in 3rd walk). 
 
5.4.2. Incorporation of 3’-O-tert-Butyldithiomethyl-dNTPs-Dye on Slide 
5.4.2.1. Preparation of Reaction Mixture 
Detailed description of the synthesis scheme and characterization for 3’-O-DTM-dNTPs and 3’-
O-DTM-dNTPs-SS-Dye are given in Jianyi Ren’s thesis ‘Design and synthesis of novel cleavable 
fluorescent nucleotide reversible terminators using disulfide linkers for DNA sequencing by 
synthesis.’64 
Materials for Surface Sequencing (all given concentrations are final)  
Dye Mixture:* 3’-O-DTM-dCTP-SS-Alexa 488 (12.0 nM-600 nM), 3’-O-DTM-dUTP-SS-R6G 
(30.0 nM-1500 nM), 3’-O-DTM-dATP-SS-Rox (2.5 nM-125 nM), 3’-O-DTM-dGTP-SS-Cy5 (3.0 
nM-150 nM). Chase Mixture:† 3’-O-DTM-dCTP (300 nM), 3’-O-DTM-dTTP (300 nM), 3’-O-
DTM-dATP (300 nM), 3’-O-DTM-dGTP (300 nM). Walking Mixture: 3’-O-DTM-dNTP (2 µM), 
3 dNTPs (1 µM). 0.1 U/µl Therminator IX DNA Polymerase (NEB), 1X Thermo Pol Reaction 
Buffer (NEB), 2 mM MnCl2, DNA Template immobilized on surface
§, H2O, SPSC Buffer (1X 
PBS pH 7.4, 0.5 M NaCl, 0.1% Tween-20), THP Solution (5 mM Tris(3-
hydroxypropyl)phosphine, 1X PBS pH 7.4), Incubator, HybriWell Hybridization System (Grace 
Bio-Labs, Cat. 611104), ScanArray Express Microarray Scanner (Perkin Elmer). 
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5.4.2.2. Procedure for 4-Color Sequencing by Synthesis on a Surface 
Step 1: Extension Reaction with Four 3’-O-DTM-dNTPs-SS-Dye 
HybriWell Hybridization System was mounted onto the DNA template slide. Extension solution 
was prepared using dye mixture*, 1X Thermo Pol Reaction Buffer, 2 mM MnCl2 and 0.1 U/µl 
Therminator IX DNA Polymerase. For the reaction the chamber was filled with reaction mixture 
(approximately 50 μl), and the slide was placed in a moisture box, and then transferred to an 
incubator set at 65oC for 15 min. For washing, the HybriWell Hybridization System was removed, 
the slide was rinsed with Milli-Q water, then immersed in SPSC Buffer at 37oC for 5 min and 
lastly rinsed with Milli-Q water and was left to air-dry. 
*Please note: Initial dye mixture concentrations (12 nM dC-Alexa; 30 nM dT-R6G; 2.5 nM dA-
Rox; 3 nM dG-Cy5) were used in the first few cycles. Concentrations were increased every 3-5 
cycles depending on results in prior cycles. By the end of a 25 cycle run, the concentrations were 
about 50-fold higher (600 nM dC-Alexa; 1500 nM dT-R6G; 125 nM dA-Rox; 150 nM dG-Cy5). 
Step 2: Imaging 
The sequence signals were acquired by running 4-channel scanning using excitation at 488 nm, 
546 nm, 594 nm and 647 nm (absorption maxima at 495 nm, 530 nm, 586 nm and 649 nm for 
R6G, ROX, Alexa488 and Cy5, respectively). The fluorescence intensity readings were recorded 
(PMT gains were adjusted appropriately), the emission filters were set at wavelengths centering at 





Step 3:  Chasing with Four 3’-O-DTM-dNTPs 
The HybriWell Hybridization System was mounted onto the DNA template slide. Chase solution 
was prepared using Chase Mixture†, 1X Thermo Pol Reaction Buffer, 2 mM MnCl2 and 0.1 U/µl 
Therminator IX DNA Polymerase. For the reaction the chamber was filled with reaction mixture 
(~50 µl), the slide was placed in a moisture box, and then transferred to an incubator set at 65oC 
for 10 min. For washing the slide was immersed in SPSC Buffer at 37oC for 5 min, rinsed with 
Milli-Q water and was left to air-dry. 
†Please note: Chase Mixture concentrations are held constant (300 nM each 3’-O-DTM-dNTP) 
through all cycles. 
Step 4: Cleavage with THP Treatment 
The HybriWell Hybridization System was mounted onto the DNA template slide. The chamber 
was filled with THP solution (~50 µl) and incubated at 65oC for 10 min. For washing, the slide 
was immersed in SPSC Buffer at 37oC for 10 min, rinsed with Milli-Q water and was left to air-
dry. The imaging step was repeated to check background recovery. 
Step 1 through Step 4 (extension*, scanning, chase, cleavage/scanning) were repeated for 
subsequent cycles of sequencing.  
*See above comment regarding increasing concentrations of 3’-O-DTM-dNTPs-SS-Dye in later 
extension cycles. 
Immobilization of DNA* The 5’-amino-modified self-priming template DNA was dissolved in 
50 mM sodium phosphate buffer, pH 9.0 at a concentration of 30 μM and spotted on NHS ester-
                                                          
* Immobilization of DNA was performed by Dr. Sergey Kalachikov.  
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activated CodeLink slides (Surmodics Inc., MN) using a SpotArray 72 microarray printing robot 
(PerkinElmer, MA). After the completion of spotting, the slides were incubated overnight in a 
humid chamber containing a solution of saturated sodium chloride at 37°C to immobilize the DNA. 
Following immobilization, unreacted NHS ester groups were quenched by incubating the slides in 
a solution of 50 mM 3-amino-1-propanol in 100 mM tris-HCl buffer, pH 9.0 for 2 hours at ambient 
temperature.  Finally, the slides were briefly rinsed in boiling water, air-dried under compressed 
air and stored desiccated in a dark container until further use. 
 
5.4.2.3. Procedure for Surface Walking 
The reactions (50 µl) were carried out using 2 µM 3’-O-DTM-dNTP, 1 µM each of remaining 
three dNTPs, 5 U Therminator IX DNA Polymerase (NEB), 1X Thermo Pol Reaction Buffer 
(NEB) and 2 mM MnCl2. The cleavage reactions were carried out using THP Solution (5 mM 
Tris(3-hydroxypropyl)phosphine, 1X PBS pH 7.4) incubated at 65oC for 5 minutes.  
Step 1: Walking Reaction with 1 3’-O-DTM-dNTP and 3 dNTPs 
The HybriWell Hybridization System was mounted onto the DNA template slide. The walking 
solution was prepared using 2 µM 3’-O-DTM-dNTP, 1 µM dNTPs, 1X Thermo Pol Reaction 
Buffer, 2 mM MnCl2 and 0.1 U/µl Therminator IX DNA Polymerase. For the reaction the chamber 
was filled with reaction mixture (approximately 50 μl) and the slide was placed in a moisture box 
and transferred to an incubator set at 65oC for 15 min. For washing, the HybriWell Hybridization 
System was removed, the slide was rinsed with Milli-Q water and immersed in SPSC Buffer at 
37oC for 5 min. Lastly the slide was rinsed with Milli-Q water and was left to air-dry. 
108 
 
Step 2: Cleavage with THP 
The HybriWell Hybridization System was mounted onto the DNA template slide. The chamber 
was filled with THP solution (~50 µl) and incubated at 65oC for 10 min. For washing, the slide 




Fluorescence-based next generation SBS technologies became the gold standard in producing 
massively parallel DNA sequencing data at very high speeds and accuracy. However, the 
technology has hit a plateau in producing long read lengths essential for many applications in 
genomic and medical research. To address a few, our initial approach demonstrated in this chapter 
can be used to visualize medium range genomic rearrangements (e.g., insertions, deletions, 
inversions, translocations) that play critical roles in development of cancer and neuropsychiatric 
disorders. Another essential application for the method would be scaffolding for de novo 
sequencing to resolve placement of repetitive sequences.  
The Sequence Walking Approach for DNA Sequencing by Synthesis we are developing is capable 
of overcoming the current challenges on increased read lengths imposed by the use of fluorescent 
nucleotide reversible terminators. By combining 4-color SBS with dNTP-containing walking 
reactions, the method can increase current read lengths at least three-fold. Our experiments with 
the method in solution and on slides showed that sequencing took place with 100% accuracy up to 
39 bases, close to the length of the template used. With the pursuit of the next set of experiments, 
where the extended primer will be stripped off and the original primer will be reattached to get 
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long, continuous sequences, The Sequence Walking Approach can increase the range of 
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